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ABSTRACT 30 
Early lifestages of the Pacific oyster (Crassostrea gigas) are highly susceptible to infection 31 
by OsHV-1 µVar, but little information exists regarding metabolic or pathophysiological 32 
responses of larval hosts. Using a metabolomics approach, we identified a range of metabolic 33 
and immunological responses in oyster larvae exposed to OsHV-1 µVar; some of which have 34 
not previously been reported in molluscs. Multivariate analyses of entire metabolite profiles 35 
were able to separate infected from non-infected larvae. Correlation analysis revealed the 36 
presence of major perturbations in the underlying biochemical networks and secondary 37 
pathway analysis of functionally-related metabolites identified a number of prospective 38 
pathways differentially regulated in virus-exposed larvae. These results provide new insights 39 
into the pathogenic mechanisms of OsHV-1 infection in oyster larvae, which may be applied 40 
to develop disease mitigation strategies and/or as new phenotypic information for selective 41 
breeding programmes aiming to enhance viral resistance. 42 
Keywords: Aquaculture, Crassostrea gigas, Larvae, Metabolism, Metabolomics, Ostreid 43 
herpesvirus  44 
1. INTRODUCTION 45 
With an estimated value of $4.17 billion USD (FAO 2016), oysters are one of the most 46 
commercially important groups of aquatic organisms in the world. In 2014, global 47 
aquaculture harvests reached 5.2 million tonnes, representing one third of all cultivated 48 
marine molluscs. Although total production volume remains high, growth of the industry has 49 
been severely hampered in recent years by extreme disease outbreaks during warmer summer 50 
months. Ostreid Herpesvirus (OsHV-1) is a new and emerging viral disease of several 51 
molluscan taxa, including oysters (Batista et al. 2015; Sanmartín et al. 2016), scallops (Arzul 52 
et al. 2001; Ren et al. 2013), and clams (Xia et al. 2015a; Bai et al. 2016). OsHV-1 has also 53 
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been detected in mussels, but without signs of infectivity or adverse consequences (Burge et 54 
al. 2011; Domeneghetti et al. 2014), making them a potential reservoir for the virus. Over the 55 
past couple of decades, OsHV-1 has been widely associated with mass mortalities of farmed 56 
oysters around the globe. A growing number of epidemiology studies and experimental trials 57 
suggest that the virus is a causal factor in these events (Friedman et al. 2005; Burge et al. 58 
2007; Segarra et al. 2010; Garcia et al. 2011; Schikorski et al. 2011a,b; Dégremont et al. 59 
2015a,b). With stock losses of up to 100%, economic and social consequences due to the 60 
spread of the disease have been devastating in countries such as France, Ireland, USA, China, 61 
Australia and New Zealand  where oyster aquaculture is a vital primary industry (Burge et al. 62 
2006; Lewis et al. 2012; Castinel et al. 2015). From the perspectives of many scientists, 63 
farmers and stakeholders alike, OsHV-1 has been articulated to represent the biggest 64 
individual threat to oyster production that the sector has ever faced (Lewis et al. 2012; 65 
Castinel et al. 2015).  66 
 First evidences for the presence of herpesvirus genetic material in bivalves was 67 
obtained in 1976 from samples of Ostrea edulis in the UK (Davison et al. 2005). However, 68 
widespread detection of herpesviruses and associations with mass mortalities of shellfish 69 
were not apparent until the early 1990’s (Renault et al. 1995). During the following decade, 70 
many occurrences of viral infections were documented around the world, and by 2005 71 
molecular characterisations had led to the designation of the pathogen as the OsHV-1 72 
reference genotype (GenBank accession no. AY509253.2) (Renault & Arzul 2001; Davison 73 
et al. 2005). More recently, there has been an emergence of numerous OsHV-1 variants 74 
affiliated with mortalities in different bivalve species displaying different epidemiological 75 
characteristics, and it appears that OsHV-1 is undergoing rapid evolution (Grijalva-Chon et 76 
al. 2013; Renault et al. 2014; Bai et al. 2015; Martenot et al. 2015). In 2008, the detection of 77 
a highly virulent new strain, OsHV-1 µVar (GenBank accession no. HQ842610.1), was 78 
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described in association with massive losses of oyster spat in France, Ireland and the UK 79 
(Segarra et al. 2010). By 2010, this new variant had reached the coasts of Australia and New 80 
Zealand, killing huge numbers of oyster stock within days and leading to sector collapses in 81 
certain regions over the following few years (Jenkins 2013; Keeling et al. 2014). Between 82 
2011 and 2013, genetic analysis of cultured oysters from China, Korea and Japan revealed 83 
widespread herpesvirus infections from numerous genotypes across the East Asiatic region 84 
(Shimahara et al. 2012; Hwang et al. 2013; Jee et al. 2013; Bai et al. 2015, 2016). High 85 
mortalities associated with OsHV-1 µVar were observed in Swedish and Norwegian 86 
hatcheries towards the end of 2014 (Mortensen et al. 2016). More recently, a new outbreak in 87 
Tasmania in 2016 has crippled the Australian oyster aquaculture sector and its selective 88 
breeding program (Davis 2016; Milne 2016; Whittington et al. 2016). Thus, it is clear that the 89 
extent of this new variant’s geographical reach is indeed a major global concern. 90 
 Due to the widespread prevalence and substantial socioeconomic consequences of 91 
OsHV-1 µVar, it is vital that knowledge of the interactions between the virus and its hosts are 92 
obtained to better understand pathogenesis of the disease, develop mitigation strategies, and 93 
guide management decisions. To provide such knowledge, a series of focused research 94 
themes relating to the spread of the virus and its mechanisms of infection have been 95 
conducted in recent years including genotyping and phylogenetics (Renault et al. 2012; 96 
Martenot et al. 2015; Mineur et al. 2015; Burioli et al. 2016), development of experimental 97 
infection models (Paul-Pont et al. 2015), modes of transmission (Burge & Friedman 2012; 98 
Lionel et al. 2013; Petton et al. 2013; Evans et al. 2016), viral replication and virulence 99 
processes (Segarra et al. 2014a, 2016; Green et al. 2015; Martenot et al. 2016), antiviral 100 
features of immunity and host responses at transcriptomic and proteomic levels (Renault et al. 101 
2011; Corporeau et al. 2014; Green et al. 2014a,b; Normand et al. 2014; Segarra et al. 102 
2014a,b; He et al. 2015) and identification of virus-resistant traits for selective breeding trials 103 
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(Dégremont 2013; Dégremont et al. 2015a,b). Most of these studies have focused on post-104 
metamorphic life stages. However, size and age are significant factors in viral susceptibility 105 
and pre-metamorphic larval forms appear to be more vulnerable than their juvenile or adult 106 
counterparts (Oden et al. 2011; Dégremont 2013; Paul-Pont et al. 2013; Azéma et al. 2016; 107 
Dégremont et al. 2016). 108 
 Many oyster farms rely on large-scale hatchery production of larvae to supply spat for 109 
growout, with increasing demand and stakeholder interests to enhance larval production 110 
capacities (Barnard 2014). Thus, it is essential that we extend our knowledge to characterise 111 
the pathophysiology of the disease during early ontogeny. Furthermore, the impacts of 112 
OsHV-1 µVar on the health of wild populations and their connectivity through larval 113 
mortalities, altered larval dispersal potentials, and reduced spat-falls are almost wholly 114 
unknown, but are likely to be substantial (Dégremont et al. 2016). In order to assess the 115 
ecological consequences of the disease and understand natural vectors and boundaries which 116 
may influence its spread, it is important to focus research across all developmental stages. In 117 
addition, the identification of specific genotypic and phenotypic traits in larvae which reflect 118 
disease susceptibility/resistance would be highly beneficial for monitoring early outcomes of 119 
selective breeding programs. Detailed physiological analysis of the host-virus interaction via 120 
use of –omics technologies (e.g., transcriptomics, proteomics and metabolomics) may 121 
provide fruitful for discovering such traits (Gómez-Chiarri et al. 2015). There are very few 122 
studies which have focused on the highly susceptible pre-metamorphic life-stage and, to our 123 
knowledge, none which have utilised metabolomic-based approaches to better understand the 124 
physiological effect of OsHV-1 infection on homeostatic control mechanisms of metabolism 125 
and immunity.  126 
 Metabolomics is a newly developing and rapidly advancing field under the –omics 127 
banner which aims to provide global snapshots of alterations in the metabolite, or small 128 
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molecule (<1 KDa), cellular component (Holmes et al. 2008). Metabolites are the ultimate 129 
end-products of gene expression and are strongly influenced by endogenous regulatory 130 
mechanisms, as well as by external elements (Fiehn 2002). As intermediates of metabolism, 131 
metabolites comprise the available biochemical depot of macromolecular precursors and 132 
energy transfer molecules required for optimal organismal growth and functioning. Thus, the 133 
composition of the metabolite pool and their flux dynamics provide a closer representation of 134 
an organism’s phenotype than molecular features at other levels of biological organisation, 135 
such as gene transcripts, which may display considerable temporal variations in expression 136 
compared to the final phenotypic response, or be entirely decoupled from downstream 137 
metabolic processes (Cascante & Marin 2008; Winter & Krömer 2013; Feussner & Polle 138 
2015). With many recent applications across the life sciences (e.g., functional genomics 139 
[Sévin et al. 2015], selective breeding [Hill et al. 2015; Hong et al. 2016], aquaculture-related 140 
research [Young et al. 2015, 2016; Alfaro & Young 2016], toxicology [Bouhifd et al. 2013; 141 
Størseth & Hammer 2014; Chen et al. 2016a] and disease diagnostics, monitoring and 142 
prevention [Pallares-Méndez et al. 2016; Wishart 2016]), metabolomics is proving extremely 143 
valuable as a highly efficient approach for generating new hypotheses and deciphering 144 
complex metabolic and gene regulatory networks of vertebrate and invertebrate models. 145 
 By scanning broad sets of metabolic features in whole organisms, tissues or biological 146 
fluids in response to environmental influences, such as bacterial or viral infections, 147 
metabolomics-based approaches can provide novel information to gain insights into the 148 
mechanisms of disease progression, resistance and remediation in aquatic organisms 149 
(reviewed by Alfaro & Young 2016; Young & Alfaro 2016). For example, metabolomics has 150 
recently been successfully applied to identify biomarkers for Vibrio spp. infections in mussels 151 
and crabs (Wu et al. 2013; Ellis et al. 2014; Su et al. 2014; Ye et al. 2016), to gain detailed 152 
metabolic information on tissue-specific host responses of shrimp and crayfish to white spot 153 
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syndrome virus (Liu et al. 2015; Chen et al. 2016b; Fan et al. 2016), and to develop practical 154 
treatment methods for streptococcal disease in fish (Ma et al. 2015; Zhao et al. 2015). 155 
Although limitedly applied to the investigation of marine invertebrate early life stages thus 156 
far, metabolomics has great potential to provide new insights into the interactions between 157 
OsHV-1 µVar and its oyster larval hosts. Thus, we have conducted the first metabolomics 158 
study to assess gross compositional alterations within the oyster larval metabolome in 159 
response to OsHV-1 infection.  160 
2.  METHODS 161 
Refer to the Supplementary Methods file for detailed method descriptors. 162 
2.1 Larval challenge 163 
OsHV-1 µVar inoculum was prepared from oysters that had been stored at −80°C and 164 
previously tested positive by qPCR (primers: GTCGCATCTTTGGATTTAACAA [BF] and 165 
ACTGGGATCCGACTGACAAC [B4], after Martenot et al. [2010]). A whole tissue 166 
homogenate was filtered and the virus concentration was determined via qPCR using BF and 167 
B4 primers in a SYBR Green assay. Oyster larvae were produced from selectively bred 168 
broodstock maintained by the Cawthron Institute (Nelson, New Zealand) and reared in a 170 169 
L conical flowthrough tank to 16 days post-fertilisation, using standard industry protocols. A 170 
cohort of healthy larvae was distributed among 12 × 2L beakers containing sterile synthetic 171 
seawater, at a density of 7 larvae mL-1. OshV-1 inoculum was added to six beakers at a 172 
concentration previously determined to cause mortality, with the remaining beakers serving 173 
as negative controls (i.e., six replicates per treatment). After 48 hrs, behavioural observations 174 
were made and all larvae were snap frozen and stored at –80°C until metabolite analysis. 175 
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2.2 Metabolite extraction, analysis and identification  176 
Metabolites were co-extracted with an internal standard using a cold methanol-water method 177 
and derivatised via methyl chloroformate (MCF) alkylation according to Villas-Bôas et al. 178 
(2011), then analysed via gas chromatography mass spectrometry (Thermo Trace GC Ultra 179 
system) according to Smart et al. (2010). Deconvolution of chromatographic data was 180 
performed using the Automated Mass Spectral Deconvolution and Identification System 181 
(AMDIS v2.66) software.  Metabolites were identified using Chemstation software (Agilent 182 
Technologies) and customised R xcms-based scripts (Aggio et al. 2011) to interrogate an in-183 
house library of MCF derivatised compounds.  184 
2.3 Statistics 185 
Peak intensity data were normalised against the internal standard and by sample-specific 186 
biomass, prior to being autoscaled. All statistical analyses were conducted using 187 
Metaboanalyst 3.0 (Xia et al. 2015b). Univariate analyses were performed to screen 188 
metabolite profile differences between controls and treatments, including foldchange 189 
analysis, students t-test , Significant Analysis of Metabolites/Microarrays (SAM) and 190 
Empirical Bayes Analysis of Metabolites/Microarrays (EBAM). Agglomerative Hierarchical 191 
Cluster Analysis (HCA), k-means clustering (kMC) and Principal Components Analysis 192 
(PCA) were used as unsupervised multivariate cluster analyses to identify natural groupings 193 
of samples based on the underlying structure of the data. Projection to Latent Structures 194 
Discriminant Analysis (PLS-DA) and Random Forrest (RF) analysis were used as supervised 195 
multivariate classification analysis methods. The PLS-DA model was validated using Leave 196 
One Out Cross Validation (LOOCV), the model performance was assessed via R2 and Q2 197 
values, and important classifiers were identified via their Variable Importance in Projection 198 
(VIP) scores. RF Receiver Operator Characteristic (ROS) curves were generated by Monte-199 
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Carlo Cross Validation (MCCV) using balanced subsampling. Quantitative Enrichment 200 
Analysis (QEA [Xia & Wishart 2010]) and Network Topology Analysis (NTA [Nikiforova & 201 
Willmitzer 2007]) were used as pathway analysis methods to investigate functional 202 
relationships among the annotated metabolites.  Biochemical pathways in the Kyoto 203 
Encyclopedia of Genes and Genomes database (Kanehisa & Goto 2000) involving two or 204 
more annotated metabolites with simultaneous QEA p-values < 0.05, QEA false discovery 205 
rates [FDRs] < 0.1, and with NTA Pathway Impact (PI) scores > 0.1 were considered as 206 
potential primary target pathways of interest. Correlation analysis was used to identify major 207 
differences in pairwise metabolite correlations (Pearson). Correlation Network Analysis 208 
(CNA) was performed to provide enhanced visualisation of metabolite relationships using 209 
Cytoscape 3.0 software (Shannon et al. 2003) and the ExpressionCorrelation plugin 210 
(Karnovsky et al. 2012).     211 
3. RESULTS 212 
The metabolite profiles of oyster larvae exposed to OsHV-1 µVar were compared to those 213 
from non-exposed control larvae in order to gain insights into the pathogenic mechanisms of 214 
infection. Observations of larval behaviour were made every 12 hrs during the trial until first 215 
signs of differences between virus-exposed larvae and controls were discerned, i.e., changes 216 
in swimming speeds, trajectories and distributions within the water column. After 48 hrs, 217 
organisms that had been challenged with OsHV-1 µVar tended to be aggregated in the lower 218 
30–50% of the water columns compared to control larvae which were more evenly 219 
distributed. When examined under the microscope, virus-exposed larvae also displayed 220 
slower motility and abnormal swimming patterns (i.e., horizontal planar circular motions 221 
rather than random) characteristic of OsHV-1 infections reported previously (Burge & 222 
Friedman 2012; DoA 2015; OIE 2016). However, larval coloration (a commonly used crude 223 
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assessment which can indicate severe poor health status) generally appeared to be visually 224 
similar between treatments. Mortality assessments revealed that 100% of oyster larvae in all 225 
beakers were alive at the time of sampling for metabolomics.  226 
3.1 Univariate analysis 227 
 GC-MS analysis of larval extracts detected a total of 105 unique metabolites after QC 228 
filtering of the data. Of these, 75 were attributed specific chemical identities by matching 229 
chromatographic and mass spectral information against our in-house metabolite library 230 
(Supplementary Table 1). The remaining 30 features are currently listed as ‘unknowns’ since 231 
no matches were found (Supplementary Table 2). Univariate statistical analyses showed a 232 
number of differences in the metabolite profiles between control and virus-infected larvae 233 
(Figure 1). SAM identified 30 metabolites as being differentially (p < 0.05) expressed 234 
between larvae exposed to OsHV-1 µVar and control larvae with an FDR of 3.1% (Figure 235 
1A), whereas EBAM identified 28 metabolites as being differentially expressed with an FDR 236 
of 4.7% (Figure 1B). The summarised results of student’s t-test, SAM and EBAM are 237 
displayed in Figure 1C, along with their relative fold changes. Taking the results of these 238 
analyses together, the abundances of nine metabolites were likely under expressed in virus-239 
infected larvae compared to the metabolic baseline of control organisms, and 20 metabolites 240 
were likely over expressed. Full details of the univariate statistical analyses are provided in 241 
Supplementary Tables 1 and 2. 242 
3.2 Unsupervised multivariate cluster analysis 243 
 Unsupervised multivariate analyses of entire metabolite profiles revealed that good 244 
separation between control and virus-infected larvae could be obtained based on the 245 
underlying structure of the data (Figure 2). HCA correctly positioned samples into two main 246 
groups (group 1, controls n = 6; group 2, treatment n = 6) (Figure 2A), indicating that the 247 
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within-class variation was considerably lower than the between-class variation. kMC 248 
corroborated this by also correctly assigning larval samples into groups based on the 249 
treatment that they received (Figure 2B; inserted table). PCA produced a 2-D score plot 250 
containing two distinct clusters of samples which appropriately reflected their class labels and 251 
with no indication of sample outliers (Figure 2C). The two clusters are separated along PC1 252 
with the relative abundances of around 40 metabolites explaining much of the divide (see 253 
Supplementary Tables 1 and 2 for the PCA loadings). Although the calculated 95% 254 
confidence interval ellipses overlapped, the accumulative variation among all samples 255 
explained by PC1 and PC2 was only 46.0%. It is therefore possible that the OsHV-1 µVar-256 
infected larval samples may be separated from control samples along other PC vectors not 257 
discernible in the 2-D score plot which might be revealed via supervised multivariate 258 
techniques.  259 
3.3 Supervised multivariate classification analysis 260 
 Supervised multivariate classification analysis was clearly able to discriminate larval 261 
samples based on the treatment they received (Figure 3). Compared to PCA, the 2-D PLS-DA 262 
score plot better separated virus-infected from control larval samples along the x-axis (Figure 263 
3A), with good cross-validated model performance using the first two latent variables 264 
(Accuracy = 100%; R2 = 96.9%; Q2 = 79.6%) (Figure 3B). PLS-DA additionally informed 265 
upon which metabolites were most important for the classification model via their VIP scores 266 
(Figure 3C). Significant classifiers for the separation between virus-infected and control 267 
groups were ranked, yielding 43 metabolites (35 annotated and 8 unannotated) with VIP 268 
scores > 1.0 (Figure 3C and Supplementary Tables 1 and 2). In addition to the 30 differing 269 
metabolite abundances identified via SAM and/or EBAM (Figure 1C), PLS-DA also 270 
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recognised 2-aminobutyric acid, glycine, hexanoic acid, homocysteine, putrescine, valine, 271 
and four additional unannotated metabolites as being important classifiers.  272 
 The RF machine learning algorithm was further employed as a complimentary feature 273 
selection method to similarly rank the most salient metabolite features responsible for class 274 
separation via a different statistical approach more resistant to over fitting than PLS-DA 275 
(Figure 4). A default RF classification model was first constructed using ten features (i.e., ~ 276 
√n) and 500 permutations, which correctly classified all samples. A series of ROC curve 277 
analyses were then performed to generate various n-feature classification models which were 278 
validated using MCCV sub-sampling to assess predictive accuracies (Figure 4A). The 279 
predictive accuracies of the 5-, 10-, and 15-feature RF models were 94.5, 98.0, and 100%, 280 
respectively, with AUC’s of 0.985, 1.0, and 1.0, respectively (Figure 4B). ROC curve 281 
analysis of the 5-feature model with corresponding confidence intervals is shown in Figure 282 
4C, and the predicted class probabilities of the model is shown in Figure 4D. The average 283 
importance and selected frequencies of metabolites in the 5-feature RF model are shown in 284 
Figure 4E and Figure 4F, respectively. Most metabolites identified as potential biomarker 285 
candidates via SAM, EBAM and PLS-DA were also selected to some degree by RF which 286 
further corroborates their significance as key classifiers of larval health condition. The most 287 
frequently selected compounds (> 20%) with high measures of average importance (> 1.0) 288 
were fumaric acid, 4-hydroxyphenylacetic acid, glutamine, glutaric acid, myristic acid, 2-289 
aminoadipic acid, and two unannotated metabolites. As indicated by RF, a low error of 290 
classification could be obtained with few compounds.   291 
3.4 Functional biochemical pathway analysis 292 
Based on the profiles of annotated metabolites, metabolic pathway analyses were performed 293 
to reveal the most relevant pathways related to the pathophysiology of oyster larvae exposed 294 
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to OsHV-1 µVar (Figure 5) (see Supplementary Table 3 for full analysis details). A total of 295 
43 biochemical pathways were recognised from within the KEGG database which contained 296 
one or more of the annotated metabolites detected. Pathways involving two or more detected 297 
metabolites and with simultaneous QEA p-values < 0.05, QEA FDR values < 0.1, and NTA 298 
Pathway Impact (PI) values > 0.1 were screened as potential primary target pathways of 299 
interest relating to the treatment effect. According to these selection criteria, 12 biochemical 300 
pathways were identified with evidence of metabolic disturbances in virus-exposed larvae 301 
(Figure 5A), comprising of: glycolysis/gluconeogenesis; pyruvate metabolism; tricarboxylic 302 
acid cycle; glyoxylate and dicarboxylate metabolism; aminoacyl-tRNA biosynthesis; tyrosine 303 
metabolism; alanine, aspartate and glutamate metabolism; arginine and proline metabolism; 304 
glycine, serine and threonine metabolism; cysteine and methionine metabolism; D-glutamine 305 
and D-glutamate metabolism; and nicotinate and nicotinamide metabolism. Nine further 306 
pathways that were identified statistically via QEA (p < 0.05) but did not meet one or more of 307 
our other ideal impact assessment criteria were screened as potential secondary target 308 
pathways of interest, comprising of: purine metabolism; pyrimidine metabolism; tryptophan 309 
metabolism, lysine degradation; nitrogen metabolism; fatty acid biosynthesis; fatty acid 310 
elongation in mitochondria; biosynthesis of unsaturated fatty acids, and fatty acid 311 
metabolism.  312 
3.5 Correlation analysis 313 
Pairwise metabolite–metabolite correlation matrices of Pearson coefficients for each 314 
treatment group were separately constructed and displayed at heatmaps (Figure 6). In general, 315 
substantial treatment-induced differences in the relationships between metabolites were 316 
exposed, as demonstrated by the many contrasting colours of same cells between the two 317 
heatmaps. From these totals of 5565 pairwise comparisons within each dataset, 167 strong 318 
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linear correlations (R2 values > 0.7 or < –0.7) were found to be highly differentially expressed 319 
(i.e., positive vs negative relationships) between larvae infected with OshV-1 µVar and 320 
baseline controls. Correlation network analyses (CNA) with selection criteria of R2 > 0.9 or < 321 
–0.9 were then separately performed on control and virus-exposed larval datasets to 322 
summarise and reveal the major correlation differences in the metabolic networks (Figure 7).  323 
4. DISCUSSION 324 
The aim of this study was to evaluate changes in the C. gigas oyster larval metabolome 325 
induced by ostreid herpesvirus and determine whether metabolomics-based approaches can 326 
deliver novel mechanistic insights into immunological defence systems of early life-stage 327 
marine invertebrates. Thus, we performed a comprehensive determination of metabolic 328 
alterations in oyster larvae exposed to the newly emerging and highly virulent OsHV-1 µVar 329 
genotype via GC/MS-based metabolomics. Our findings revealed that viral exposure had an 330 
effect on many metabolites involved in central carbon metabolism, across broad chemical 331 
classes with various functional roles. These virus-induced changes in the metabolite profiles 332 
enabled us to discriminate healthy from unhealthy larvae via multivariate clustering and 333 
classification techniques, discern relationships among metabolites, identify entire 334 
biochemical pathways evidenced of being altered, and further focused our attention towards 335 
specific mechanisms of immunity characteristic of the pathophysiological condition. We 336 
identified coordinated changes in tricarboxylic acid (TCA) cycle-related metabolites in virus-337 
exposed larvae indicative of abnormal energy metabolism and biosynthesis of an 338 
antimicrobial product, and also detected subtle signs of potential oxidative stress, 339 
transformation or degradation of extracellular matrix scaffolding, and disruption of normal 340 
lipid metabolism suggestive of requirements for viral appropriation of host-cell biomaterial, 341 
among other processes. Confirmation of these hypotheses based on the metabolomics data 342 
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will require further investigation using functional assays at other levels of biological 343 
organisation.    344 
4.1 Lipid metabolism 345 
Enveloped viruses, such as those from the herpesviridae family, are known to physically and 346 
metabolically remodel host cells during infection to create optimal environments for their 347 
replication by manipulating lipid signalling and metabolism (Chukkapalli et al. 2012; 348 
Rosenwasser et al. 2016). Such viruses instructively alter host metabolism in order to supply 349 
the high quantities of fatty acids which are required as vital lipid envelope components during 350 
virion assembly (Koyuncu et al. 2013). Although the precise induction mechanisms have not 351 
yet been elucidated, enrichment of host fatty acid (FA) production is a common response of 352 
different organisms to infection by various enveloped viruses (Mazzon & Mercer 2014; Hsieh 353 
et al. 2015; Sanchez & Lagunoff 2015), including herpes-type viruses such as human 354 
cytomegalovirus (HMCV) (Spencer et al. 2011; Seo et al. 2013; Purdy et al. 2015) and 355 
Kaposi’s sarcoma-associated herpesvirus (Bhatt et al. 2012). An emerging theme is that these 356 
lipid-modifying pathways are linked to innate antiviral responses which can be modulated to 357 
inhibit viral replication (Chukkapalli et al. 2012). For example, HCMV stimulates free fatty 358 
acid (FFA) production to enable and enhance assembly of infectious virions by activating 359 
expression of ACC1 host mRNA, the gene encoding for the rate-limiting enzyme acetyl-CoA 360 
carboxylase (ACC) involved in the initial commitment stage of de novo FA synthesis 361 
(Spencer et al. 2011); whereas pharmacological inhibition of host ACC substantially limits 362 
the ability of HCMV to replicate (Munger et al. 2008). More recently, Koyuncu et al. (2013) 363 
reported that siRNA-induced knockdown of a suite of other enzymes involved in FA 364 
synthesis (fatty acyl-CoA synthetases and elongases) inhibited herpesvirus replications, 365 
whereas knockdown of proteins responsible for FA catabolism (the peroxisomal β-oxidation 366 
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enzyme acetyl-CoA acyl-transferase 1) and the first step of triglyceride synthesis (1-367 
acylglycerol-3-phosphate O-acyltransferase 9) enhanced viral replication by elevating the 368 
available FFA pool. Thus, the FA synthesis pathway is currently gaining considerable 369 
attention as a prime target for the development of innovative therapeutics that are not 370 
dependent on mechanisms of adaptive immunity, and therefore resilient to emerging virus 371 
variants which have become resistant to anti-viral therapies (Goodwin et al. 2015).  372 
 Looking at the global metabolic changes in larvae induced by OsHV-1 µVar 373 
exposure, there was a signature consisting of FFAs, presumably involving either a change in 374 
the relative rates of production and/or breakdown. These variation patterns contributed 375 
towards earmarking FA pathways (FA metabolism, FA β-oxidation and FA elongation in 376 
mitochondria) as being candidate targets of interest in our study via secondary bioinformatics 377 
techniques, and also were key metabolites causative to the perturbations observed within the 378 
differential metabolic correlation networks. Under the starvation conditions we employed 379 
during the viral challenge, an effect on basal lipolysis would be the most obvious potential 380 
mechanism for the FFA changes observed here. Compared to non-infected control larvae, the 381 
general increase in medium and long chain FFAs (C16:0, C18:3n-6, C20:4n-6, C20:5n-3, 382 
C22:2n6, C22:6n-3) and microalgal-derived dietary FFAs (C14:0, C16:1n-7) in virus-infected 383 
larvae are indicative of enhanced catabolism of endogenous triacylglycerol lipid supplies. 384 
This pre-metamorphic host-response appears to be somewhat similar to that of post-385 
metamorphic life stages. Proteomic-based analyses of adult Pacific oysters experimentally 386 
infected with OsHV-1 µVar recently identified that a key enzyme involved in the first step of 387 
lipid hydrolysis, triacylglycerol lipase (TGL), was over-accumulated in virus-exposed 388 
animals which likely reflects enhanced lipolysis during initial stages of infection (Corporeau 389 
et al. 2014). Furthermore, transcriptomic-based analyses revealed over-expression of genes 390 
encoding for TGL and phospholipase A2 (an enzyme that releases FAs from the second 391 
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carbon group of glycerol in phospholipids) in OsHV-1 µVar-infected oysters (He et al. 2015), 392 
and several other studies also report triglyceride levels being substantially decreased in 393 
juvenile and adult oyster hosts exposed to the virus (Pernet et al. 2010, 2014; Tamayo et al. 394 
2014).  In adult oysters, FFA accumulations do not appear to coincide with the reduced lipid 395 
contents following OsHV-1 µVar infection likely due to them being transitory intermediates 396 
(Tamayo et al. 2014), for which simultaneously enhanced rates of β-oxidation could explain. 397 
However, infected adult oysters display a down-accumulation in fatty acid-binding protein 398 
(FABP) (Corporeau et al. 2014), a chaperone involved in trafficking FFAs across the 399 
mitochondrial membrane, and, at the height of the viral load, decreased Fabp transcription 400 
and expression of a gene encoding the alpha subunit of FA oxidation complex (He et al. 401 
2015), all of which would limit β-oxidation rather than promote it. Thus, aside from being 402 
used for host energy metabolism, the FFAs produced during virus-induced lipolysis in oysters 403 
may be used as precursor synthesis molecules for constructing the lipid envelope during virus 404 
assembly and proliferation; as previously reported for HCMV infections.  405 
 Although FFA levels at a particular time reflect the complex metabolic balance 406 
between lipolysis, β-oxidation, and any other FA production (e.g., de novo synthesis) or 407 
consuming processes (e.g., triglyceride synthesis and utilisation for virion assembly), the 408 
FFA accumulations we observed are consistent with the general findings of other studies 409 
which have investigated various models of herpes-type infections. Perhaps a key point of 410 
difference in host-virus interactions between OsHV-1 and vertebrate-infecting herpesviruses 411 
could be the primary source from which the FAs are derived from (i.e., lipolysis vs de novo 412 
synthesis). We recommend that targeted analyses of these pathways are additionally 413 
conducted at transcriptional and translational levels, in combination with metabolite profiling, 414 
in order to tease out the mechanistic intricacies of OsHV-1 µVar-induced modulation of host 415 
lipid metabolism in oyster larvae. With FAs being necessary components required for OsHV-416 
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1 replication and proliferation, establishing the precise viral targets of host lipid metabolism 417 
could assist in the development of antiviral therapeutics, and/or identification of unique 418 
disease resistant genomic or metabolic traits for selective breeding purposes.   419 
4.2  TCA cycle and immunoresponsive gene 1 420 
Host metabolism changes are suggestive of immunoresponsive gene 1 (Irg1) like activation, 421 
which directly affects carbon flux through the TCA cycle and modifies energy metabolism. 422 
Irg1 is commonly and highly expressed in vertebrate macrophages during inflammation and 423 
infection by a variety of pathogens (Preusse et al. 2013). Irg1 encodes immune-responsive 424 
gene 1 protein/ cis-aconitic acid decarboxylase (IRG1/CAD) which links cellular metabolism 425 
with immune defence by catalysing the decarboxylation of cis-aconitic acid (the citrate → 426 
isocitrate isomerisation intermediate in the TCA cycle) to itaconic acid (ITA) (Michelucci et 427 
al. 2013; Vuoristo et al. 2015). ITA is a metabolite with potent antimicrobial properties 428 
(Naujoks et al. 2016), and was identified in our study as being over-accumulated in virus-429 
exposed oyster larvae. ITA being discovered as the gene product of Irg1 is arguably one of 430 
the most important biological insights made in recent times (Sévin et al. 2015), and was only 431 
revealed through taking a non-hypothesis driven metabolomics profiling approach as we have 432 
in the current study. ITA has newly been recognised as a crucial regulatory metabolite 433 
involved in posttranscriptional mechanisms of reprogramming mitochondrial metabolism 434 
through modulation of substrate level phosphorylation, TCA cycle flux and succinic acid 435 
signalling (Mills & O’Neill 2016; Cordes et al. 2016; Németh et al. 2016), production of 436 
inflammatory cytokines (Lampropoulou et al. 2016) and its ability to alter cellular redox 437 
balance (Tretter et al. 2016).  438 
 Upregulation of Irg1 transcription leads to a characteristic metabolic signature of a 439 
“broken TCA cycle” in stimulated macrophages (O’Neill 2015; O’Neill & Pearce 2016; 440 
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O’Neill et al. 2016). ITA accumulation represents the first of two distinctive break-points in 441 
the pathway due to decreased transcription of isocitrate dehydrogenase (IDH; catalyses 442 
isocitrate → α-ketoglutarate), and the redirection of cis-aconitic acid metabolism via enriched 443 
Irg1-encoded IRG1/CAD expression (Jha et al. 2015; Yanamoto et al. 2015). The increased 444 
production of ITA decreases citric acid oxidation through the cycle. To compensate for the 445 
reduced flux under such conditions, Maisser et al. (2016) showed that glutamine uptake is co-446 
enhanced with Irg1 expression, serving to replenish the pathway with α-ketoglutaric acid 447 
through glutaminolysis. In agreement, the reduction in free glutamine content that we 448 
observed in OsHV-1 µVar-exposed larvae is consistent with such an anaplerotic mechanism. 449 
Herpes-infected human cells can switch substrate utilisation from glucose to glutamine to 450 
accommodate the biosynthetic and energetic needs of the viral infection, and allow glucose to 451 
alternatively be used biosynthetically (Chambers et al. 2010). Virus-induced reprogramming 452 
of glutamine metabolism and anaplerosis of the TCA cycle at this particular point appears to 453 
be critical for successful replication of herpes-type viruses, as well as maintenance of cellular 454 
viability during latent infections (Sanchez et al. 2015; Thai et al. 2015). 455 
 The second characteristic break-point in the TCA cycle occurs at succinate 456 
dehydrogenase/ respiratory Complex II (SDH/CII), the enzyme which catalyses the oxidation 457 
of succinate → fumarate, and also crucially regulates respiration in the electron transport 458 
chain (Mills & O’Neill 2016). ITA is a competitive inhibitor of SDH/CII (Cordes et al. 2016), 459 
and thus, when ITA levels increase, enzyme activity is attenuated leading to an accumulation 460 
of succinic acid and a concomitant decrease in oxidative phosphorylation (OxPhos) 461 
(Lampropoulou et al. 2016). Directly in line with this second TCA cycle break-point feature, 462 
oyster larvae exposed to OsHV-1 µVar exhibited elevated levels of succinic acid. The 463 
functional purpose of reprogramming host cell metabolism to accumulate succinic acid in 464 
response to pathogen infections appears to stem in part from its ability to mediate 465 
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inflammatory responses. Aside from having a fundamental role in the TCA cycle, succinic 466 
acid can act as a regulatory signal, via succinate receptor 1 (GPR91/SUCNR1), to induce 467 
production of pro-inflammatory cytokines (TNF-α, IL-1β) which can enhance immune-468 
stimulatory capacity, but also can exasperate disease when produced in excess (Rubic et al. 469 
2008; Tannahill et al. 2013; Mills & O’Neill 2014; Littlewood-Evans et al. 2016). 470 
GPR91/SUCNR1 is therefore involved in sensing the immunological danger exposed by 471 
Irg1/ITA-induced succinic acid accumulations, thus further establishing direct links between 472 
immunity and cellular respiration.  473 
 Rather than downstream TCA cycle intermediates being depleted as a consequence of 474 
this second break at SDH/CII, the metabolic response involves enrichment of the aspartate-475 
arginosuccinate shunt pathway which provides a compensatory mechanism to replenish the 476 
system (Jha et al. 2015), thus leading to significant increases in levels of fumaric and malic 477 
acids regardless of SDH/CII inhibition (Lampropoulou et al. 2016). In agreement, both of 478 
these TCA metabolites were over-accumulated in virus-exposed larvae. Thus, our metabolite 479 
data suggest that larval oyster cells have a comparable host response to OsHV-1 µVar as 480 
mammalian macrophages when stimulated or infected with other viruses. To the best of our 481 
knowledge, this is the first report of such metabolic reprogramming of the TCA cycle in an 482 
invertebrate with the specific metabolite signature of pathogen-induced Irg1 transcription 483 
directly in accordance with vertebrate cell models. How OsHV-1 might stimulate genomic 484 
components leading to activation of Irg1 transcription in oysters is not known, but would 485 
likely share some parallels with mechanisms of higher taxa (see Owens & Malham 2015; 486 
Naujoks et al. 2016; Tallam et al. 2016). 487 
  Only two cases of Irg1 involvement in marine mollusc immune responses 488 
have thus far been reported. Martín-Gómez et al. (2012) detected an up-regulation of Irg1 489 
transcription in the flat oyster, Ostrea edulis, exposed to Bonamiosis disease under light and 490 
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heavy infection scenarios, which suggest that Irg1 could play a role at early infection stages 491 
with prolonged expression at later stages. Furthermore, although not stated nor discussed in 492 
their manuscript, He et al. (2015 [supplementary material]) identified via untargeted gene 493 
expression profiling that the C. gigas Irg1 transcript was over-expressed 9-fold in adult 494 
oysters exposed to OsHV-1 at the height of the viral replication process. In combination with 495 
our findings of a classic metabolic signature for Irg1 over-expression and enhanced aconitase 496 
activity in virus-exposed larvae, these data are supportive of an active role of Irg1 and its 497 
metabolic product, ITA, in the innate immunity of oysters, and further provide the first 498 
reports of such associated pathophysiological mechanisms of disease in marine invertebrates. 499 
Moreover, these data also suggest that this particular metabolic reprogramming mechanism 500 
develops very early in the oyster lifecycle, and is a conserved feature of immunity across the 501 
metamorphic boundary. These findings provide fresh insights into the early evolution of 502 
innate immunity. We suggest that a detailed characterisation of this system, including 503 
endogenous regulatory networks and exogenous effectors, be conducted through ontogeny 504 
which may provide useful information for identifying disease resistant traits. Investigation of 505 
other mechanisms associated with altered host energy metabolism, such as the Warburg 506 
effect, may also deliver important insights into the pathophysiology of the disease.    507 
4.3 Warburg effect 508 
The Warburg effect is an abnormal metabolic shift that was first discovered in proliferating 509 
cancer cells (Ferreira 2010). It has since been detected in vertebrate cells infected by viruses 510 
(Delgado et al. 2010, 2012; Darekar et al. 2012; Thai et al. 2014), and was recently 511 
implicated as an actuated pathway during viral infections in shrimp and oysters (Corporeau et 512 
al. 2014; Su et al. 2014; Hsieh et al. 2015; Fan et al. 2016; Li et al. 2016). Herpes-type 513 
viruses are known to activate oncogenes, thus providing a mechanistic link with cancerous 514 
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cell phenotypes (Mesri et al. 2014). The Warburg effect is distinguished by a high rate of 515 
glycolytic flux and unusual aerobic fermentation of glucose to lactic acid even though there is 516 
enough oxygen available for OxPhos to proceed (Kelly & O’Neill 2015). It is often 517 
accompanied by the activation or enrichment of other metabolic pathways that provide 518 
energy and direct the flow of carbon and nitrogen, such as the pentose phosphate pathway, 519 
nucleotide biosynthesis, lipolysis, and glutaminolysis (Zaidi et al. 2013; Tannahill et al. 2013; 520 
Su et al. 2014; Sanchez & Lagunoff 2015; Li et al. 2016), and also with mechanisms of innate 521 
immunity such as Irg1 activation/ ITA over-accumulation (Kelly & O’Neill 2015). 522 
 Metabolic alterations characteristic of the Warburg effect involves increased 523 
glycolysis, elevated levels of lactic acid, and changes in rates of nicotinamide adenine 524 
dinucleotide phosphate (NADPH) production/utilisation. These effects result from the 525 
diversion of glucose metabolism, glutamine oxidation, and requirements of reducing 526 
equivalents for FA biosynthesis and for mounting anti-oxidant responses to Reactive Oxygen 527 
Species (ROS) via re-oxidisation of glutathione (vander Heiden et al. 2009; Weljie & Jirik 528 
2011; Senyilmaz & Teleman 2015). Although the precise initiating mechanism/s responsible 529 
for reprogramming the glycolytic and gluconeogenic pathways that result in these metabolite 530 
changes are not yet completely understood (Vijayakumar et al. 2015), succinic acid 531 
accumulations act as an innate immunity regulatory signal to trigger a switch in core 532 
metabolism from OxPhos to glycolysis. Succinic acid stabilises the alpha subunit of hypoxia 533 
inducible factor 1 (HIF-1α) thereby activating transcription of genes which downregulates 534 
OxPhos (e.g., via indirect inhibition of pyruvate kinase to reduce TCA cycle flux), enhances 535 
glycolysis (e.g., via increased production of hexokinase and glucose transporters), and 536 
promotes lactic acid production (e.g., via regulation of lactate dehydrogenase and 537 
monocarboxylate transporter 4) (Ben-Shlomo et al. 1997; Selak et al. 2005; Semenza 2010; 538 
Palsson-McDemott & O’Neill 2013; Tannahill et al. 2013; Mills & O’Neill 2014). Thus, with 539 
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ITA-induced inhibition of SDH/CII, succinic acid may be an important metabolite linking 540 
Irg1 activation with the Warburg effect in virus infected cells. 541 
 Compared to baseline control larvae, lactic acid was over-accumulated in OsHV-1 542 
µVar-exposed larvae, whereas NADPH levels were lower. Secondary bioinformatics analysis 543 
of the metabolomics data also recognised glycolysis/gluconeogenesis and nucleotide 544 
metabolism as being differentially modulated as a larval host response to the virus, which 545 
could reflect an active Warburg-like effect. Our findings align with those of Corporeau et al. 546 
(2014) who utilised a proteomic-based approach to assess global protein changes in adult 547 
oysters infected with OsHV-1 µVar. Altered host protein expressions included changes in 548 
mitochondrial membrane permeability (accumulation of voltage-dependant anion channels 549 
[VDAC]), and enhanced glycolysis via an increase in the glycolytic enzyme Triose phosphate 550 
isomerase and decreases in the gluconeogenic enzymes Fructose 1,6-biphosphatase and 551 
Malate dehydrogenase (MDH); signatures which resemble induction of the Warburg effect 552 
(Chen et al. 2011; Maldonado & Lemasters 2012; Corporeau et al. 2014). Supporting the 553 
findings of Corporeau et al. (2014), increased and decreased expressions of genes encoding 554 
VDAC and MDH, respectively, were detected in adult oysters exposed to the virus (Renault 555 
et al. 2011; He et al. 2015). Taken together, these characteristic evidences at various levels of 556 
organisation (i.e., gene, protein and metabolite) suggest an involvement of the Warburg effect 557 
as a pathophysiological feature of OsHV-1 µVar infection.  558 
 It is thought that the Warburg effect in cancer cells is adapted to facilitate the uptake 559 
and incorporation of nutrients into the biomass needed to produce new cells during 560 
proliferation at the expense of efficient, albeit slow, ATP production via OxPhos (vander 561 
Heiden et al. 2009; Zhang et al. 2012). The functional purpose for selection of energy 562 
inefficient lactic acid fermentation over OxPhos in virus-exposed oysters is less clear. 563 
However, it is possible that the Warburg effect is ‘strategically’ induced by OsHV-1 as a 564 
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metabolic reprogramming mechanism beneficial to the pathogen. With the catabolism of 565 
glucose exceeding the bioenergetics needs of cells during Warburg activation (Thomas 2014), 566 
the high yields of intermediates created through enriched glycolysis and a truncated TCA 567 
cycle could be used for production of purine and pyrimidine nucleotides and other 568 
components required for viral DNA synthesis and envelope assembly. Aerobic fermentation 569 
would also provide energy for these processes more swiftly than through OxPhos and with 570 
less risk of constraining glycolytic flux via ATP-induced negative feedback inhibition (Zhang 571 
et al. 2012; Sanchez & Lagunoff 2015), thus facilitating rapid and persistent viral replication.  572 
4.4 Oxidative stress 573 
We hypothesised that significant changes in the abundances of metabolites reflective of 574 
oxidative stress would be represented in OsHV-1 Var-exposed oyster larvae. Exposure to 575 
invading pathogens initially triggers robust innate immune responses, and a rapid release of 576 
reactive oxygen species (ROS) called an oxidative burst is usually registered soon afterwards 577 
(Torres et al. 2006).  ROS are beneficial since they can facilitate degradation of invading 578 
pathogen biomaterial, and also act as signalling molecules to potentiate other immune 579 
responses, such as activation of interferons and their regulatory factors (Chiang et al. 2006). 580 
However, when produced in excess, they can cause irreparable damage to crucial host cells 581 
through degradation of macromolecular cellular components, including lipids, proteins, and 582 
DNA (Pisoschi & Pop 2015). During viral infections, this can actually promote virus 583 
proliferation by enhancing dispersion from lysed or apoptotic cells (Stehbens 2004). Thus, 584 
oxidative bursts should ideally be reduced before attaining critical levels, and can be achieved 585 
through an intricate balance of co-regulated antioxidant processes. These include production 586 
of the antioxidant metabolite glutathione (GSH) and a number of enzymes which regulate 587 
GSH turnover, directly recycles ROS, or are involved in repairing ROS-induced damage 588 
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(Knight 2000; Apel & Hirt 2004). Adult and juvenile oysters exposed to OsHV-1, or showing 589 
variable susceptibilities to disease associated with the virus, display differential expression of 590 
these enzymes, and/or the genes which encode them (Fleury et al. 2010; Fleury & Huvet 591 
2012; Schmitt et al. 2013; Normand et al. 2014; Corporeau et al. 2014; He et al. 2015). This 592 
indicates a change in ROS balance and induction of oxidative stress as a response to the 593 
infection, and also suggests that the ROS-regulatory system is an important feature which 594 
underpins disease resistance.  595 
 We detected a relatively high coverage of metabolites within the glutathione 596 
metabolism pathway. However, subtle variations of metabolites central to network topology, 597 
such as glutathione itself, were not differentially expressed resulting in the entire pathway 598 
being only marginally affected (p = 0.057). On the other hand, the transulphuration pathway 599 
(cysteine and methionine metabolism) which is responsible for supplying precursor 600 
metabolites for glutathione synthesis under low-mid stress conditions was altered, which 601 
indicates a mild oxidative stress response. The subtle signs of oxidative stress and perturbed 602 
redox balance in virus-exposed larvae indicate that the homeostatic control mechanisms 603 
responsible for governing the production and detoxification of ROS were functioning at 604 
optimal capacities and well within acceptable boundaries. These findings suggest that OsHV-605 
1 either does not induce major oxidative stress in oyster larvae beyond the adaptive ability of 606 
the ROS-regulatory system, or that the level or stage of infection in our study was low or 607 
early, respectively. These results also may highlight a potential limitation in the exclusive use 608 
of metabolomic-based approaches to recognise changes in metabolic activity under 609 
circumstances where enzymatic regulation tightly constrains metabolite levels within the 610 
range of normal baseline variations. Indeed, cellular metabolism, and glutathione turnover/ 611 
ROS regulation in particular, is extremely well-adapted to achieve this feat. Thus, to better 612 
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define the influence of OsHV-1 on oxidative stress parameters, further analysis of enzymes 613 
associated with glutathione recycling and ROS regulation would be required. 614 
4.5 Other signatures 615 
A number of other metabolites were considered to be important features responsible for larval 616 
health class discrimination in PCA, PLS-DA and RF models. These included elevated levels 617 
of 4-hydroxyphenylacetic acid, 4-hydroxyproline, and 2-aminoadipic acid and a reduction in 618 
nicotinic acid contents. Four unannotated metabolites were also important in the multivariate 619 
models. Future efforts to identify these molecules may further complement our interpretations 620 
or provide new insights into the virus-host interaction.  621 
 4-hydroxyphenylacetic acid (4-HPA) is a tyrosine-derived metabolite with antioxidant 622 
activity that can scavenge reactive oxygen and nitrogen species in vitro and in vivo (Biskup et 623 
al. 2013), and also has an ability to reduce excessive release of proinflammatory cytokines 624 
which protects against inflammation and disease (Liu et al. 2014; Ford et al. 2016). Increased 625 
levels of 4-HPA are associated with various mammalian disease pathologies and inborn 626 
errors in metabolism (Kikuchi et al. 2010; Nishiumi et al. 2010; Hori et al. 2011; Manna et al. 627 
2015; Xiong et al. 2015; Kurko et al. 2016). An accumulation of this metabolite during such 628 
disease onsets has been attributed to differential catabolic pathways of tyrosine (Xiong et al. 629 
2015). In our study, tyrosine metabolism was identified as a pathway with signs of being 630 
differentially regulated. It was recently demonstrated that the mechanism by which 4-HPA 631 
reduces proinflammatory cytokine production involves suppression of their transcription via 632 
promotion of HIF-1α protein degradation (Liu et al. 2014). Thus, with a functional role in 633 
downregulating HIF-1 activity, 4-HPA could directly compete with Irg1/ITA/succinic acid-634 
induced HIF-1α stabilisation. As a result, HIF-1 induced enrichment of pathways responsible 635 
for redirecting carbon and nitrogen metabolism in trajectories which support OsHV-1 636 
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proliferation might be moderated, whereas the negative host consequences associated with 637 
co-induced respiratory dysfunction and excessive inflammation may partially be alleviated. 638 
 4-hydroxyproline (4-HP) is produced via the posttranslational hydroxylation of 639 
proline and is formed in proteins only after peptide linkage (Cooper et al. 2008). 4-HP is 640 
predominantly found in collagen, a major structural component of the extracellular matrix 641 
(ECM) scaffold in marine invertebrate embryos and larvae (Spiegel et al. 1989; Phang et al. 642 
2010). Thus, accumulation of free 4-HP is a specific biomarker of collagen degradation, and 643 
indicator of cell structure damage through compositional transformation of the ECM (Karna 644 
& Palka 2002; Phang et al. 2008). The production of free 4-HP resulting from ECM 645 
degradation is thought to play a role in initiating the apoptotic cascade  via activation of the 646 
caspase-9 protease (Cooper et al. 2008), as well as promoting HIF-1 activity by inhibiting the 647 
degradation of HIF-1α (Surazynski et al. 2008). Matrix metalloproteinases (MMPs), are 648 
responsible for degrading the ECM. MMPs play crucial roles during normal embryonic and 649 
larval development, such as in cell growth and differentiation, tissue remodelling, and 650 
mechanisms of immunological defense (Mannello et al. 2003, 2005; Mok et al. 2009). 651 
However, MMPs can be excessively produced in pathological situations  (Itoh et al. 2006; 652 
Phang et al. 2008). Physical stress, oncogenic transformation, ROS and cytokines are all 653 
inducible factors (Mancini & Battista 2006; Reuter et al. 2010). MMPs and their importance 654 
in restructuring the ECM as a response to pathogens have previously been implicated in 655 
OsHV-1 infections and disease resistance vs susceptibility traits of oysters (McDowell et al. 656 
2014; Nikapitiya et al. 2014; Rosani et al. 2015). The elevated levels of free 4-HP in OsHV-1 657 
µVar-exposed larvae indicates that collagen degradation in the ECM was enhanced, although 658 
further investigation will be required to determine whether the 4-HP accumulations represent 659 
negative consequences for the host due to significant cell structure damage.  660 
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 2-aminoadipic acid (2-AAA) is a component of the lysine metabolism pathway and is 661 
recognised as a small-molecule biomarker of oxidative stress (Sell et al. 2007; Zeitoun-662 
Ghandour et al. 2011). Its presence has been linked with regulation of glucose homeostasis 663 
(Yuan et al. 2011; Wang et al. 2013), and elevated levels have been reported as a putative 664 
biosignature of respiration chain disorders (Smuts et al. 2013). Production of 2-AAA in fish 665 
is associated with low oxygen transport capacity (Allen et al. 2015), and can be induced in 666 
shellfish by exposure to physiological stressors (Chen et al. 2015; Koyama et al. 2015). 667 
Accumulations of 2-AAA are also associated with oncogene activation and carcinogenesis, 668 
leading to its recent candidacy as a potential new clinical biomarker for various cancers (Hori 669 
et al. 2011; Bellance et al. 2012; Jung et al. 2013; Rosi et al. 2015; Ren et al. 2016). 670 
Production of 2-AAA correlates with the bioenergetic signature characteristic of a switch in 671 
cellular respiration modes from OxPhos to aerobic glucose fermentation (Hori et al. 2011; Aa 672 
et al. 2012; Bellance et al. 2012). Thus, the accumulation of 2-AAA in virus-exposed larvae 673 
is consistent with the global changes we detected in organic acid metabolism reflective of 674 
TCA cycle reprogramming, reduced mitochondrial respiration and ATP production, 675 
activation of the Warburg effect, and subtle signs of oxidative stress. 676 
 Nicotinic acid (NA) plays an important role in redox reactions and can be converted 677 
to nicotinamide (NAM) in vivo. In invertebrates and some fish, NA and NAM are important 678 
precursors for synthesis of the pyrimidine nucleotide coenzymes NAD+ and NADP+ which 679 
participate in many hydrogen transfer processes, such as fatty acid synthesis, lipolysis and 680 
glycolysis (Ng et al. 1997; Sauve 2008; Houtkooper et al. 2009; Cantó et al. 2015; Yuasa & 681 
Ball 2015; Yuasa et al. 2015). NAD+ is also a substrate and signalling metabolite required for 682 
regulation of transcription, proteasomal function, and posttranslational protein modifications 683 
involved in DNA replication, recombination, repair mechanisms and maintenance of genomic 684 
stability (Bürkle 2001; Surjana et al. 2010; Vyas et al. 2013; Fouquerel & Sobol 2014; Cantó 685 
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et al. 2015). Unlike most metabolic redox reactions which reversibly oxidise or reduce 686 
pyrimidine nucleotides to maintain constant levels of NAD+/NADP+, substrate utilisation and 687 
NAD+-dependant signalling processes are highly consumptive, and regeneration from niacin 688 
precursors is required when such mechanisms are activated (Lin 2007; Chiarugi et al. 2012). 689 
The reduction of free NA in virus-exposed larvae is consistent with its role in these processes 690 
which are upregulated during herpes-type viral infections (Grady et al. 2012; Li et al. 2012). 691 
Herpes-induced consumption of NAD+ as a substrate for enzymes involved in host DNA 692 
modifications is likely a response to DNA damage pathways being activated by replication of 693 
the viral genome (Grady et al. 2012). However, efficient virus replication itself and synthesis 694 
of viral proteins are also reliant on NAD+ substrate supply (Li et al. 2012). Thus, the 695 
importance of NA and NAD+/NADP+ metabolism in host-pathogen interactions is gaining 696 
considerable attention as targets for the treatment of infectious diseases in humans (Mesquita 697 
et al. 2016). Interestingly, activation of the Warburg effect involves the unusual 698 
overproduction of NAD+ via enhanced fermentation of glucose (i.e., pyruvic acid + NADH 699 
→ lactic acid + NAD+) (Chiarugi et al. 2012), and may serve/function as a replenishing 700 
mechanism in response to NAD+ depletion to complement de novo synthesis from its niacin 701 
precursors. 702 
4.6 Study limitations 703 
During an infection, viruses have an ability to alter host metabolites in order to benefit their 704 
replication. However, the host can also mount responses against the pathogen via changes in 705 
host metabolism pathways, such as triggering inflammation. Unfortunately, at this early stage 706 
of the research we do not know which metabolic features have roles in virus pathogenesis and 707 
which of the signatures can be attributed to host defence. This is an important aspect to 708 
decipher, and will require highly focused investigation. A critical step to achieve this will be 709 
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to characterise the functional genome of OsHV-1 µVar. Furthermore, our study did not 710 
include a temporal sampling design. During an infection, viruses can trigger various 711 
metabolic changes at different replication stages. For example, the Warburg effect may be 712 
triggered at the stage of virus genome replication, whereas lipid metabolism may be altered at 713 
the stage of virion assembly prior to release of mature virion particles from host cells. In 714 
order to contextualise host metabolic perturbations within the framework of viral 715 
propagation, future efforts should be made to incorporate a fine scale temporal sampling 716 
design, analysis of multiple targets (genes, proteins and metabolites), and a detailed 717 
characterisation of the virus replication process; although, lack of bivalve cell lines continue 718 
to hamper virus research in these taxa (Yoshino & Bayne 2013).    719 
5. CONCLUSION 720 
In summary, we identified and measured the metabolic responses of oyster larvae during 721 
exposure to the virulent ostreid herpesvirus microvariant which has recently been responsible 722 
for mass mortalities of shellfish around the globe. Viruses can reshape their host’s 723 
metabolism to create a unique metabolic state that supports their specific requirements. 724 
Indeed, profiling of larval metabolites revealed virus-induced reprogramming of host-725 
encoded metabolic networks, including alterations to the glycolytic pathway, the TCA cycle, 726 
and lipid metabolism. Intriguingly, we observed metabolic response parallels with a number 727 
of innate immune system mechanisms previously characterised in mammalian cell models, 728 
such as induction of the Warburg effect and downstream metabolic consequences of 729 
immunoresponsive gene 1 like activation. The functional genomes of OsHV-1 and its 730 
variants are mostly unknown at present, but it is likely that virus-encoded auxiliary genes also 731 
provide infected host cells with novel metabolic capabilities, and the outcomes of their 732 
transcription may be manifested within our results. These findings provide the first 733 
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comprehensive insights into early ontogenic host physiology and susceptibility of oysters 734 
towards OsHV-1 µVar. Characterisation of host-virus interactions can provide knowledge to 735 
enable development of therapeutic agents and identify traits for improving the outcome of 736 
selective breeding programmes. Our study also highlights the value of metabolomics-based 737 
approaches in elucidating host-virus interactions and the metabolic networks which 738 
characterise and underpin the pathophysiological state, and further supports its application for 739 
investigating pathogenesis of disease in early life stage oyster models. 740 
ACKNOWLEDGEMENTS 741 
We would like to thank the crew at the Cawthron Aquaculture Park for their support and 742 
guidance: Norman Ragg, Serean Adams, Zoë Hilton, Steve Webb, Samantha Gale, Henry 743 
Kaspar, and Mark Camara.  We are thankful to the Aquaculture Biotechnology Group (AUT) 744 
for their input and support through this research.  We are also thankful to Francesca Casu and 745 
Erica Zarate from University of Auckland for their technical assistance with sample analysis. 746 
We acknowledge support from an Auckland University of Technology Vice Chancellor 747 
Doctoral Scholarship to T. Young under the supervision of A.C. Alfaro.  This work was 748 
funded by the New Zealand Ministry of Business, Innovation and Employment (CAWX0802 749 
and CAWX1315).  750 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
REFERENCES 751 
 752 
Aa, J., Yu, L., Sun, M., Liu, L., Li, M., Cao, B., et al., 2012. Metabolic features of the tumor 753 
microenvironment of gastric cancer and the link to the systemic macroenvironment. 754 
Metabolomics, 8(1), 164–173. 755 
Alfaro, A.C., Young, T., 2016. Showcasing metabolomics research in aquaculture: A review. 756 
Rev. Aquacult., DOI: 10.1111/raq.12152 757 
Allen, P.J., Wise, D., Greenway, T., Khoo, L., Griffin, M.J., Jablonsky, M., 2015. Using 1-D 758 
1H and 2-D 1H J-resolved NMR metabolomics to understand the effects of anemia in 759 
channel catfish (Ictalurus punctatus). Metabolomics, 11(5), 1131–1143. 760 
Apel, K., Hirt, H., 2004. Reactive oxygen species: Metabolism, oxidative stress, and signal 761 
transduction. Annu. Rev. Plant Biol., 55, 373–399. 762 
Arzul, I., Nicolas, J.-L., Davison, A.J., Renault, T., 2001. French scallops: A new host for 763 
ostreid herpesvirus-1. Virology, 290, 342–349. 764 
Azéma P., Travers, M.A., Benabdelmouna, A., Dégremont, L., 2016. Single or dual 765 
experimental infections with Vibrio aestuarianus and OsHV-1 in diploid and triploid 766 
Crassostrea gigas at the spat, juvenile and adult stages. J. Invertebr. Pathol., 139, 92–767 
101. 768 
Bai, C., Gao, W., Wang, C., Yu, T., Zhang, T., Qiu, Z., et al., 2016. Identification and 769 
characterization of ostreid herpesvirus 1 associated with massive mortalities of 770 
Scapharca broughtonii broodstocks in China. Dis. Aquat. Organ., 118(1), 65–75. 771 
Bai, C., Wang, C., Xia, J., Sun, H., Zhang, S., Huang, J., 2015. Emerging and endemic types 772 
of Ostreid herpesvirus 1 were detected in bivalves in China. J. Invertebr. Pathol., 124, 773 
98–106. 774 
Barnard, R., 2014. Determining the Need for a Multi-Species Mollusc Hatchery in Western 775 
Australia: ACWA Study Report. Australian Community Workers Association Mollusc 776 
Hatchery Report prepared by RMB Aqua, Albany, WA, Australia. 777 
Batista, F.M., López-Sanmartín, M., Grade, A., Morgado, I., Valente, M., Navas, J.I., et al., 778 
2015. Sequence variation in ostreid herpesvirus 1 microvar isolates detected in dying and 779 
asymptomatic Crassostrea angulata adults in the Iberian Peninsula: Insights into viral 780 
origin and spread. Aquaculture, 435, 43–51. 781 
Bellance, N., Pabst, L., Allen, G., Rossignol, R., Nagrath, D., 2012. Oncosecretomics coupled 782 
to bioenergetics identifies α-amino adipic acid, isoleucine and GABA as potential 783 
biomarkers of cancer: Differential expression of c-Myc, Oct1 and KLF4 coordinates 784 
metabolic changes. BBA-Bioenergetics, 1817(11), 2060–2071. 785 
Ben-Shlomo, I., Kol, S., Roeder, L.M., Resnick, C.E., Hurwitz, A., Payne, D.W., et al., 1997. 786 
Interleukin (IL)-1β increases glucose uptake and induces glycolysis in aerobically 787 
cultured rat ovarian cells: Evidence that IL-1β may mediate the gonadotropin-induced 788 
midcycle metabolic shift. Endocrinology, 138(7), 2680–2688. 789 
Bhatt, A.P., Jacobs, S.R., Freemerman, A.J., Makowski, L., Rathmell, J.C., Dittmer, D.P., et 790 
al., 2012. Dysregulation of fatty acid synthesis and glycolysis in non-Hodgkin 791 
lymphoma. P. Natl. Acad. Sci. U. S. A., 109(29), 11818–11823. 792 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
Biskup, I., Golonka, I., Gamian, A., Sroka, Z., 2013. Antioxidant activity of selected phenols 793 
estimated by ABTS and FRAP methods. Postep. Hig. Med. Dosw., 67, 958–963. 794 
Bouhifd, M., Hartung, T., Hogberg, H.T., Kleensang, A., Zhao, L., 2013. Review: 795 
Toxicometabolomics. J. Appl. Toxicol., 33(12), 1365–1383. 796 
Braundmeier-Fleming, A., Russell, N.T., Yang, W., Nas, M.Y., Yaggie, R.E., Berry, M., et 797 
al., 2016. Stool-based biomarkers of interstitial cystitis/bladder pain syndrome. Sci. Rep., 798 
DOI: 10.1038/srep26083 799 
Burge, C.A., Griffin, F.J., Friedman, C.S., 2006. Mortality and herpesvirus infections of the 800 
Pacific oyster Crassostrea gigas in Tomales Bay, California, USA. Dis. Aquat. Organ., 801 
72(1), 31–43. 802 
Burge, C., Judah, L.R., Conquest, L.L., Griffin, F.J., Cheney, D.P., Suhrbier, A., et al., 2007. 803 
Summer seed mortality of the Pacific oyster, Crassostrea gigas Thunberg grown in 804 
Tomales Bay, California, U. S. A.: The influence of oyster stock, planting time, 805 
pathogens, and environmental stressors. J. Shellfish Res., 26, 163–172. 806 
Burge, C.A., Strenge, R.E., Friedman, C.S., 2011. Detection of the oyster herpesvirus in 807 
commercial bivalves in northern California, USA: Conventional and quantitative PCR. 808 
Dis. Aquat. Organ., 94(2), 107–116. 809 
Burge, C.A., Friedman, C.S., 2012. Quantifying ostreid herpesvirus (OsHV-1) genome copies 810 
and expression during transmission. Microb. Ecol., 63(3), 596–604. 811 
Burioli, E.A.V., Prearo, M., Riina, M.V., Bona, M.C., Fioravanti, M.L., Arcangeli, G., et al., 812 
2016. Ostreid herpesvirus type 1 genomic diversity in wild populations of Pacific oyster 813 
Crassostrea gigas from Italian coasts. J. Invertebr. Pathol., 137, 71–83. 814 
Bürkle, A., 2001. Physiology and pathophysiology of poly (ADP‐ribosyl) ation. Bioessays, 815 
23(9), 795–806. 816 
Cameron, S.J., Lewis, K.E., Beckmann, M., Allison, G.G., Ghosal, R., Lewis, P.D., et al., 817 
2016. The metabolomic detection of lung cancer biomarkers in sputum. Lung Cancer, 94, 818 
88–95. 819 
Cantó, C., Menzies, K.J., Auwerx, J., 2015. NAD+ metabolism and the control of energy 820 
homeostasis: A balancing act between mitochondria and the nucleus. Cell Metab., 22(1), 821 
31–53. 822 
Cascante, M., Marin, S., 2008. Metabolomics and fluxomics approaches. Essays Biochem., 823 
45, 67–82. 824 
Castinel, A, Fletcher, L, Dhand, N, Rubio, A, Whittington, R, Taylor, M., 2015. OsHV-1 825 
mortalities in Pacific Oysters in Australia and New Zealand: The Farmer’s Story. 826 
Prepared for the Ministry of Business, Innovation and Employment (MBIE). Cawthron 827 
Report No. 2567. 48 p. 828 
Chambers, J.W., Maguire, T.G., Alwine, J.C., 2010. Glutamine metabolism is essential for 829 
human cytomegalovirus infection. J. Virol., 84(4), 1867–1873. 830 
Chen, D.Q., Chen, H., Chen, L., Tang, D.D., Miao, H., Zhao, Y.Y., 2016a. Metabolomic 831 
application in toxicity evaluation and toxicological biomarker identification of natural 832 
product. Chem.-Biol. Interact., 252, 114–130. 833 
Chen, I.T., Lee, D.Y., Huang, Y.T., Kou, G.H., Wang, H.C., Chang, G.D., et al., 2016b. Six 834 
hours after infection, the metabolic changes induced by WSSV neutralize the host’s 835 
oxidative stress defenses. Sci. Rep., 6, Article number 27732. 836 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
Chen, S., Zhang, C., Xiong, Y., Tian, X., Liu, C., Jeevithan, E. et al., 2015. A GC-MS-based 837 
metabolomics investigation on scallop (Chlamys farreri) during semi-anhydrous living-838 
preservation. Innov. Food Sci. Emerg., 31, 185–195. 839 
Chiang, E., Dang, O., Anderson, K., Matsuzawa, A., Ichijo, H., David, M., 2006. Cutting 840 
edge: Apoptosis-regulating signal kinase 1 is required for reactive oxygen species-841 
mediated activation of IFN regulatory factor 3 by lipopolysaccharide. J. Immunol., 842 
176(10), 5720–5724. 843 
Chiarugi, A., Dölle, C., Felici, R., Ziegler, M., 2012. The NAD metabolome – a key 844 
determinant of cancer cell biology. Nat. Rev. Cancer, 12(11), 741–752. 845 
Chukkapalli, V., Heaton, N.S., Randall, G., 2012. Lipids at the interface of virus–host 846 
interactions. Curr. Opin. Microbiol., 15(4), 512–518. 847 
Cooper, S.K., Pandhare, J., Donald, S.P., Phang, J.M., 2008. A novel function for 848 
hydroxyproline oxidase in apoptosis through generation of reactive oxygen species. J. 849 
Biol. Chem., 283(16), 10485–10492. 850 
Cordes, T., Wallace, M., Michelucci, A., Divakaruni, A.S., Sapcariu, S. ., Sousa, C., et al., 851 
2016. Immunoresponsive gene 1 and itaconate inhibit succinate dehydrogenase to 852 
modulate intracellular succinate levels. J. Biol. Chem., 291(27), 14274–14284. 853 
Corporeau, C., Tamayo, D., Pernet, F., Quéré, C., Madec, S., 2014. Proteomic signatures of 854 
the oyster metabolic response to herpesvirus OsHV-1 µVar infection. J. Proteomics, 109, 855 
176–187. 856 
Darekar, S., Georgiou, K., Yurchenko, M., Yenamandra, S.P., Chachami, G., Simos, G., et 857 
al., 2012. Epstein-Barr virus immortalization of human B-cells leads to stabilization of 858 
hypoxia-induced factor 1 alpha, congruent with the Warburg effect. PLOS ONE, 7(7), 859 
e42072. 860 
Davis, J., 2016. A National Industry Response to Pacific Oyster Mortality Syndrome 861 
(POMS). An Agribusiness Tasmanian report commissioned by Oysters Australia Ltd, 862 
Tasmania, Australia. 863 
Davison, A.J., Trus, B.L., Cheng, N., Steven, A.C., Watson, M.S., Cunningham, C., et al., 864 
2005. A novel class of herpesvirus with bivalve hosts. J. Gen. Virol., 86(1), 41–53. 865 
Dégremont, L., 2013. Size and genotype affect resistance to mortality caused by OsHV-1 in 866 
Crassostrea gigas. Aquaculture, 416, 129–134. 867 
Dégremont, L., Lamy, J.B., Pépin, J.F., Travers, M.A., Renault, T., 2015a. New insight for 868 
the genetic evaluation of resistance to Ostreid herpesvirus infection, a worldwide disease, 869 
in Crassostrea gigas. PLOS ONE, 10(6), e0127917. 870 
Dégremont, L., Nourry, M., Maurouard, E., 2015b. Mass selection for survival and resistance 871 
to OsHV-1 infection in Crassostrea gigas spat in field conditions: Response to selection 872 
after four generations. Aquaculture, 446, 111–121. 873 
Dégremont, L., Morga, B., Trancart, S., Pépin, J.F., 2016. Resistance to OsHV-1 infection in 874 
Crassostrea gigas larvae. Front. Mar. Sci., 3, DOI: 10.3389/fmars.2016.00015 875 
Delgado, T., Sanchez, E.L., Camarda, R., Lagunoff, M., 2012. Global metabolic profiling of 876 
infection by an oncogenic virus: KSHV induces and requires lipogenesis for survival of 877 
latent infection. PLOS Pathog., 8(8), e1002866. 878 
DoA, 2015. AQUAVETPLAN disease strategy: Infection with ostreid herpesvirus-1 879 
microvariant (Version 1), In: Australian Aquatic Veterinary Emergency Plan 880 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
(AQUAVETPLAN). Australian Government Department of Agriculture (DoA), 881 
Canberra, ACT, Australia. 882 
Domeneghetti, S., Varotto, L., Civettini, M., Rosani, U., Stauder, M., Pretto, T., et al., 2014. 883 
Mortality occurrence and pathogen detection in Crassostrea gigas and Mytilus 884 
galloprovincialis close-growing in shallow waters (Goro lagoon, Italy). Fish Shellfish 885 
Immunol., 41(1), 37–44. 886 
Ellis, R.P., Spicer, J.I., Byrne, J.J., Sommer, U., Viant, M.R., White, D.A., et al., 2014. 1H 887 
NMR metabolomics reveals contrasting response by male and female mussels exposed to 888 
reduced seawater pH, increased temperature, and a pathogen. Environ. Sci. Technol., 889 
48(12), 7044–7052. 890 
Evans, O., Hick, P., Whittington, R.J., 2016. Distribution of Ostreid herpesvirus-1 (OsHV-1) 891 
microvariant in seawater in a recirculating aquaculture system. Aquaculture, 458, 21–28. 892 
Fan, W., Ye, Y., Chen, Z., Shao, Y., Xie, X., Zhang, W., et al., 2016. Metabolic product 893 
response profiles of Cherax quadricarinatus towards white spot syndrome virus 894 
infection. Dev. Comp. Immunol., 61, 236–241. 895 
FAO, 2016b. Global Aquaculture Production dataset (online query). 896 
http://www.fao.org/fishery/statistics/global-aquaculture-production/query/en (accessed 897 
19.09.2016). Food and Agriculture Organisation of the United Nations (FAO), Fisheries 898 
and Aquaculture Department, Rome, Italy. 899 
Ferreira, L.M., 2010. Cancer metabolism: The Warburg effect today. Exp. Mol. Pathol., 900 
89(3), 372–380. 901 
Feussner, I., Polle, A., 2015. What the transcriptome does not tell—proteomics and 902 
metabolomics are closer to the plants’ patho-phenotype. Curr. Opin. Plant Biol., 26, 26–903 
31. 904 
Fiehn, O., 2002. Metabolomics – the link between genotypes and phenotypes. Plant Mol. 905 
Biol. Rep., 48(1–2), 155–171. 906 
Fleury, E., Moal, J., Boulo, V., Daniel, J.Y., Mazurais, D., Hénaut, A., et al., 2010. 907 
Microarray-based identification of gonad transcripts differentially expressed between 908 
lines of Pacific oyster selected to be resistant or susceptible to summer mortality. Mar. 909 
Biotechnol., 12(3), 326–339. 910 
Fleury, E., Huvet, A., 2012. Microarray analysis highlights immune response of Pacific 911 
oysters as a determinant of resistance to summer mortality. Mar. Biotechnol., 14(2), 203–912 
217. 913 
Ford, C.T., Richardson, S., McArdle, F., Lotito, S.B., Crozier, A., McArdle, A., et al., 2016. 914 
Identification of (poly) phenol treatments that modulate the release of pro-inflammatory 915 
cytokines by human lymphocytes. Br. J. Nutr., 115(10), 1699–1710. 916 
Fouquerel, E., Sobol, R.W., 2014. ARTD1 (PARP1) activation and NAD+ in DNA repair and 917 
cell death. DNA Repair, 23, 27–32. 918 
Friedman, C.S., Estes, R.M., Stokes, N.A., Burge, C.A., Hargove, J.S., Barber, B.J., et al., 919 
2005. Herpes virus in juvenile Pacific oysters Crassostrea gigas from Tomales Bay, 920 
California, coincides with summer mortality episodes. Dis. Aquat. Organ., 63, 33–41. 921 
Garcia, C., Thébault, A., Dégremont, L., Arzul, I., Miossec, L., Robert, M., et al., 2011. 922 
OsHV-1 detection and relationship with C. gigas spat mortality in France between 1998 923 
and 2006. Vet. Res., 42, 73–84. 924 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
Gómez-Chiarri, M., Guo, X., Tanguy, A., He, Y., Proestou, D., 2015. The use of-omic tools 925 
in the study of disease processes in marine bivalve mollusks. J. Invertebr. Pathol., 131, 926 
137–154. 927 
Goodwin, C.M., Xu, S., Munger, J., 2015. Stealing the keys to the kitchen: Viral 928 
manipulation of the host cell metabolic network. Trends Microbiol., 23(12), 789–798. 929 
Grady, S.L., Hwang, J., Vastag, L., Rabinowitz, J.D., Shenk, T., 2012. Herpes simplex virus 930 
1 infection activates poly (ADP-ribose) polymerase and triggers the degradation of poly 931 
(ADP-ribose) glycohydrolase. J. Virol., 86(15), 8259–8268. 932 
Green, T.J., Robinson, N., Chataway, T., Benkendorff, K., O’Connor, W., Speck, P., 2014a. 933 
Evidence that the major hemolymph protein of the Pacific oyster, Crassostrea gigas, has 934 
antiviral activity against herpesviruses. Antiviral Res., 110, 168–174. 935 
Green, T.J., Montagnani, C., Benkendorff, K., Robinson, N., Speck, P., 2014b. Ontogeny and 936 
water temperature influences the antiviral response of the Pacific oyster, Crassostrea 937 
gigas. Fish Shellfish Immunol., 36(1), 151–157. 938 
Green, T.J., Rolland, J.L., Vergnes, A., Raftos, D., Montagnani, C., 2015. OsHV-1 939 
countermeasures to the Pacific oyster's anti-viral response. Fish Shellfish Immunol., 940 
47(1), 435–443. 941 
Grijalva‐Chon, J.M., Castro‐Longoria, R., Ramos‐Paredes, J., Enríquez‐Espinoza, T.L., 942 
Mendoza‐Cano, F., 2013. Detection of a new OsHV‐1 DNA strain in the healthy Pacific 943 
oyster, Crassostrea gigas Thunberg, from the Gulf of California. J. Fish Dis., 36(11), 944 
965–968. 945 
He, Y., Jouaux, A., Ford, S.E., Lelong, C., Sourdaine, P., Mathieu, M., et al., 2015. 946 
Transcriptome analysis reveals strong and complex antiviral response in a mollusc. Fish 947 
Shellfish Immunol., 46(1), 131–144. 948 
Hill, C.B., Taylor, J.D., Edwards, J., Mather, D., Langridge, P., Bacic, A., et al., 2015. 949 
Detection of QTL for metabolic and agronomic traits in wheat with adjustments for 950 
variation at genetic loci that affect plant phenology. Plant Sci., 233, 143–154. 951 
Holmes, E., Wilson, I.D., Nicholson, J.K., 2008. Metabolic phenotyping in health and 952 
disease. Cell, 134(5),714–717. 953 
Hong, J., Yang, L., Zhang, D., Shi, J., 2016. Plant metabolomics: An indispensable system 954 
biology tool for plant science. Int. J. Mol. Sci., 17(6), E767, DOI: 10.3390/ijms17060767 955 
Hori, S., Nishiumi, S., Kobayashi, K., Shinohara, M., Hatakeyama, Y., Kotani, Y., et al., 956 
2011. A metabolomic approach to lung cancer. Lung Cancer, 74(2), 284–292. 957 
Houtkooper, R.H., Cantó, C., Wanders, R.J., Auwerx, J., 2010. The secret life of NAD+: An 958 
old metabolite controlling new metabolic signaling pathways. Endocr. Rev., 31(2), 194–959 
223. 960 
Hsieh, Y.C., Chen, Y.M., Li, C.Y., Chang, Y.H., Liang, S.Y., Lin, S.Y., et al., 2015. To 961 
complete its replication cycle, a shrimp virus changes the population of long chain fatty 962 
acids during infection via the PI3K-Akt-mTOR-HIF1α pathway. Dev. Comp. Immunol., 963 
53(1), 85–95. 964 
Hwang, J.Y., Park, J.J., Yu, H.J., Hur, Y.B., Arzul, I., Couraleau, Y., et al., 2013. Ostreid 965 
herpesvirus 1 infection in farmed Pacific oyster larvae Crassostrea gigas (Thunberg) in 966 
Korea. J. Fish Dis., 36(11), 969–972. 967 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
Itoh, M., Murata, T., Suzuki, T., Shindoh, M., Nakajima, K., Imai, K., et al., 2006. 968 
Requirement of STAT3 activation for maximal collagenase-1 (MMP-1) induction by 969 
epidermal growth factor and malignant characteristics in T24 bladder cancer cells. 970 
Oncogene, 25(8), 1195–1204. 971 
Jee, B.Y., Lee, S.J., Cho, M.Y., Lee, S.J., Kim, J.W., Choi, S.H., et al., 2013. Detection of 972 
ostreid herpesvirus 1 from adult Pacific oysters Crassostrea gigas cultured in Korea. J. 973 
Kor. Fish. Aqua. Sci., 16(2), 131–135. 974 
Jenkins, C., Hick, P., Gabor, M., Spiers, Z., Fell, S.A., Gu, X., et al., 2013. Identification and 975 
characterisation of an ostreid herpesvirus-1 microvariant (OsHV-1 µ-var) in Crassostrea 976 
gigas (Pacific oysters) in Australia. Dis. Aquat. Organ., 105(2), 109–126. 977 
Jha, A.K., Huang, S.C.C., Sergushichev, A., Lampropoulou, V., Ivanova, Y., Loginicheva, 978 
E., et al., 2015. Network integration of parallel metabolic and transcriptional data 979 
reveals metabolic modules that regulate macrophage polarization. Immunity, 42(3), 980 
419–430. 981 
Jung, K., Reszka, R., Kamlage, B., Bethan, B., Stephan, C., Lein, M., et al., 2013. Tissue 982 
metabolite profiling identifies differentiating and prognostic biomarkers for prostate 983 
carcinoma. Int. J. Cancer, 133(12), 2914–2924. 984 
Kalantari, S., Nafar, M., Samavat, S., Parvin, M., Fatemeh, B., Barzi, F., 2016. 1H NMR-985 
based metabolomics exploring urinary biomarkers correlated with proteinuria in focal 986 
segmental glomerulosclerosis: A pilot study. Magn. Reson. Chem., 54(10), 821–826. 987 
Kanehisa, M., Goto, S., 2000. KEGG: Kyoto Encyclopedia of Genes and Genomes. Nucleic 988 
Acids Res., 28, 27–30. 989 
Karna, E., Pałka, J.A., 2002. Inhibitory effect of acetylsalicylic acid on metalloproteinase 990 
activity in human lung adenocarcinoma at different stages of differentiation. Eur. J. 991 
Pharmacol., 443(1), 1–6. 992 
Karnovsky, A., Weymouth, T., Hull, T., Tarcea, V.G., Scardoni, G., Laudanna, C., et al., 993 
2012. Metscape 2 bioinformatics tool for the analysis and visualization of metabolomics 994 
and gene expression data. Bioinformatics, 28(3), 373–380. 995 
Keeling, S.E., Brosnahan, C.L., Williams, R., Gias, E., Hannah, M., Bueno, R., et al., 2014. 996 
New Zealand juvenile oyster mortality associated with ostreid herpesvirus 1—an 997 
opportunistic longitudinal study. Dis. Aquat. Organ., 109, 231–239. 998 
Kelly, B., O'Neill, L.A., 2015. Metabolic reprogramming in macrophages and dendritic cells 999 
in innate immunity. Cell Res., 25(7), 771–784. 1000 
Kikuchi, K., Itoh, Y., Tateoka, R., Ezawa, A., Murakami, K., Niwa, T., 2010. Metabolomic 1001 
analysis of uremic toxins by liquid chromatography/electrospray ionization-tandem mass 1002 
spectrometry. J. Chromatogr. B Biomed. Sci. Appl., 878(20), 1662–1668. 1003 
Knight, J.A., 2000. Review: Free radicals, antioxidants, and the immune system. Ann. Clin. 1004 
Lab. Sci., 30(2), 145–158. 1005 
Koyama, H., Okamoto, S., Watanabe, N., Hoshino, N., Jimbo, M., Yasumoto, K., et al., 2015. 1006 
Dynamic changes in the accumulation of metabolites in brackish water clam Corbicula 1007 
japonica associated with alternation of salinity. Comp. Biochem. Physiol. B Biochem. 1008 
Mol. Biol., 181, 59–70. 1009 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
Koyuncu, E., Purdy, J.G., Rabinowitz, J.D., Shenk, T., 2013. Saturated very long chain fatty 1010 
acids are required for the production of infectious human cytomegalovirus progeny. 1011 
PLOS Pathog., 9(5), e1003333. 1012 
Kurko, J., Tringham, M., Tanner, L., Näntö-Salonen, K., Vähä-Mäkilä, M., Nygren, H., et al., 1013 
2016. Imbalance of plasma amino acids, metabolites and lipids in patients with lysinuric 1014 
protein intolerance (LPI). Metabolism, 65(9), 1361–1375. 1015 
Lampropoulou, V., Sergushichev, A., Bambouskova, M., Nair, S., Vincent, E.E., 1016 
Loginicheva, E., et al., 2016. Itaconate links inhibition of succinate dehydrogenase with 1017 
macrophage metabolic remodeling and regulation of inflammation. Cell Metab., 24(1), 1018 
158–166. 1019 
Lewis, T., Defenderfer, D., Zippel, B., 2012. Understanding and Planning for the otential 1020 
Impacts of OsHV-1 µVar on the Australian Pacific oyster Industry. Final report (FRDC 1021 
2011/043), 1 September 2012. RDS Partners, Hobart, Australia, pp. 1–21. 1022 
Li, C.Y., Wang, Y.J., Huang, S.W., Cheng, C.S., Wang, H.C., 2016. Replication of the 1023 
shrimp virus WSSV depends on glutamate-driven anaplerosis. PLOS ONE, 11(1), 1024 
e0146902. 1025 
Li, Z., Yamauchi, Y., Kamakura, M., Murayama, T., Goshima, F., Kimura, H., et al., 2012. 1026 
Herpes simplex virus requires poly (ADP-ribose) polymerase activity for efficient 1027 
replication and induces extracellular signal-related kinase-dependent phosphorylation 1028 
and ICP0-dependent nuclear localization of tankyrase 1. J. Virol., 86(1), 492–503. 1029 
Lin, H., 2007. Nicotinamide adenine dinucleotide: beyond a redox coenzyme. Org. Biomol. 1030 
Chem., 5(16), 2541–2554. 1031 
Lionel, D., Guyader, T., Tourbiez, D., Pépin, J.F., 2013. Is horizontal transmission of the 1032 
Ostreid herpesvirus OsHV-1 in Crassostrea gigas affected by unselected or selected 1033 
survival status in adults to juveniles? Aquaculture, 408, 51–57. 1034 
Littlewood-Evans, A., Sarret, S., Apfel, V., Loesle, P., Dawson, J., Zhang, J., et al., 2016. 1035 
GPR91 senses extracellular succinate released from inflammatory macrophages and 1036 
exacerbates rheumatoid arthritis. J. Exp. Med., 213(9), 1655–1662. 1037 
Liu, P.F., Liu, Q.H., Wu, Y., Jie, H., 2015. A pilot metabolic profiling study in 1038 
hepatopancreas of Litopenaeus vannamei with white spot syndrome virus based on 1H 1039 
NMR spectroscopy. J. Invertebr. Pathol., 124, 51–56. 1040 
Liu, Z., Xi, R., Zhang, Z., Li, W., Liu, Y., Jin, F., et al., 2014. 4-Hydroxyphenylacetic acid 1041 
attenuated inflammation and edema via suppressing HIF-1α in seawater aspiration-1042 
induced lung injury in rats. Int. J. Mol. Sci., 15(7), 12861–12884.  1043 
Ma, Y.M., Yang, M.J., Wang, S., Li, H., Peng, X.X., 2015. Liver functional metabolomics 1044 
discloses an action of L-leucine against Streptococcus iniae infection in tilapias. Fish 1045 
Shellfish Immunol., 45(2), 414–421. 1046 
Maldonado, E.N., Lemasters, J.J., 2012. Warburg revisited: Regulation of mitochondrial 1047 
metabolism by voltage-dependent anion channels in cancer cells. J. Pharmacol. Exp. 1048 
Ther., 342(3), 637–641. 1049 
Mancini, A., di Battista, J.A., 2006. Transcriptional regulation of matrix metalloprotease gene 1050 
expression in health and disease. Front. Biosci., 11, 423–446. 1051 
Manna, S.K., Thompson, M.D., Gonzalez, F.J., 2015. Application of mass spectrometry-1052 
based metabolomics in identification of early noninvasive biomarkers of alcohol-induced 1053 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
liver disease using mouse model, In: Biological Basis of Alcohol-Induced Cancer. 1054 
Springer International Publishing AG, Switzerland, pp. 217–238. 1055 
Mannello, F., Canesi, L., Faimali, M., Piazza, V., Gallo, G., Geraci, S., 2003. 1056 
Characterization of metalloproteinase-like activities in barnacle (Balanus amphitrite) 1057 
nauplii. Comp. Biochem. Physiol. B Biochem. Mol. Biol., 135(1), 17–24. 1058 
Mannello, F., Tonti, G., Papa, S., 2005. Are matrix metalloproteinases the missing link. 1059 
Invertebrate Surviv. J., 2(69), 69–74. 1060 
Martenot, C., Oden, E., Travaille, E., Malas, J.P., Houssin, M., 2010. Comparison of two 1061 
real-time PCR methods for detection of ostreid herpesvirus 1 in the Pacific oyster 1062 
Crassostrea gigas. J. Virol. Methods, 170(1), 86–89. 1063 
Martenot, C., Lethuillier, O., Fourour, S., Oden, E., Trancart, S., Travaillé, E., et al., 2015. 1064 
Detection of undescribed ostreid herpesvirus 1 (OsHV-1) specimens from Pacific oyster, 1065 
Crassostrea gigas. J. Invertebr. Pathol., 132, 182–189. 1066 
Martenot, C., Segarra, A., Baillon, L., Faury, N., Houssin, M., Renault, T., 2016. In situ 1067 
localization and tissue distribution of ostreid herpesvirus 1 proteins in infected Pacific 1068 
oyster, Crassostrea gigas. J. Invertebr. Pathol., 136, 124–135. 1069 
Martín-Gómez, L., Villalba, A., Abollo, E., 2012. Identification and expression of immune 1070 
genes in the flat oyster Ostrea edulis in response to bonamiosis. Gene, 492(1), 81–93. 1071 
Mazzon, M., Mercer, J., 2014. Lipid interactions during virus entry and infection. Cell. 1072 
Microbiol., 16(10), 1493–1502. 1073 
McDowell, I.C., Nikapitiya, C., Aguiar, D., Lane, C.E., Istrail, S., Gomez-Chiarri, M., 2014. 1074 
Transcriptome of American oysters, Crassostrea virginica, in response to bacterial 1075 
challenge: Insights into potential mechanisms of disease resistance. PLOS ONE, 9(8), 1076 
e105097. 1077 
Meiser, J., Krämer, L., Sapcariu, S.C., Battello, N., Ghelfi, J., D'Herouel, A.F., et al., 2016. 1078 
Pro-inflammatory macrophages sustain pyruvate oxidation through pyruvate 1079 
dehydrogenase for the synthesis of itaconate and to enable cytokine expression. J. Biol. 1080 
Chem., 291(8), 3932–3946. 1081 
Mesquita, I., Varela, P., Belinha, A., Gaifem, J., Laforge, M., Vergnes, B., et al., 2016. 1082 
Exploring NAD+ metabolism in host–pathogen interactions. Cell. Mol. Life Sci., 73(6), 1083 
1225–1236. 1084 
Mesri, E.A., Feitelson, M.A., Munger, K., 2014. Human viral oncogenesis: A cancer 1085 
hallmarks analysis. Cell Host Microbe, 15(3), 266–282. 1086 
Michelucci, A., Cordes, T., Ghelfi, J., Pailot, A., Reiling, N., Goldmann, O., et al., 2013. 1087 
Immune-responsive gene 1 protein links metabolism to immunity by catalyzing itaconic 1088 
acid production. P. Natl. Acad. Sci. U. S. A., 110(19), 7820–7825. 1089 
Mills, E., O’Neill, L.A., 2014. Succinate: A metabolic signal in inflammation. Trends Cell 1090 
Biol., 24(5), 313–320. 1091 
Mills, E.L., O'Neill, L.A., 2016. Reprogramming mitochondrial metabolism in macrophages 1092 
as an anti‐inflammatory signal. Eur. J. Immunol., 46(1), 13–21. 1093 
Milne, B., 2016. Outbreak of ‘POMS' in Tasmanian hatchery offers new insight into ostreid 1094 
herpesvirus. Hatchery Int., May 2016. 1095 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
Mineur, F., Provan, J., Arnott, G., 2015. Phylogeographical analyses of shellfish viruses: 1096 
Inferring a geographical origin for ostreid herpesviruses OsHV-1 (Malacoherpesviridae). 1097 
Mar. Biol., 162(1), 181–192. 1098 
Mok, F.S., Thiyagarajan, V., Qian, P.Y., 2009. Proteomic analysis during larval development 1099 
and metamorphosis of the spionid polychaete Pseudopolydora vexillosa. Proteome Sci., 1100 
7(1), 1–11. 1101 
Mortensen, S., Strand, Å., Bodvin, T., Alfjorden, A., Skår, C.K., Jelmert, A., et al., 2016. 1102 
Summer mortalities and detection of ostreid herpesvirus microvariant in Pacific oyster 1103 
Crassostrea gigas in Sweden and Norway. Dis. Aquat. Organ., 117(3), 171–176. 1104 
Munger, J., Bennett, B.D., Parikh, A., Feng, X.J., McArdle, J., Rabitz H.A., et al., 2008. 1105 
Systems-level metabolic flux profiling identifies fatty acid synthesis as a target for 1106 
antiviral therapy. Nat. Biotechnol., 26(10), 1179–1186. 1107 
Naujoks, J., Tabeling, C., Dill, B.D., Hoffmann, C., Brown, A.S., Kunze, M., et al., 2016. 1108 
IFNs modify the proteome of legionella-containing vacuoles and restrict infection via 1109 
IRG1-derived itaconic acid. PLOS Pathog., 12(2), e1005408. 1110 
Németh, B., Doczi, J., Csete, D., Kacso, G., Ravasz, D., Adams, D., et al., 2016. Abolition of 1111 
mitochondrial substrate-level phosphorylation by itaconic acid produced by LPS-1112 
induced Irg1 expression in cells of murine macrophage lineage. FASEB J., 30(1), 286–1113 
300. 1114 
Ng, W.K., Serrini, G., Zhang, Z., Wilson, R.P., 1997. Niacin requirement and inability of 1115 
tryptophan to act as a precursor of NAD+ in channel catfish, Ictalurus punctatus. 1116 
Aquaculture, 152(1), 273–285. 1117 
Nikapitiya, C., McDowell, I.C., Villamil, L., Muñoz, P., Sohn, S., Gomez-Chiarri, M., 2014. 1118 
Identification of potential general markers of disease resistance in American oysters, 1119 
Crassostrea virginica through gene expression studies. Fish Shellfish Immunol., 41(1), 1120 
27–36. 1121 
Nikiforova, V.J., Willmitzer, L., 2007. Network visualization and network analysis, in: 1122 
Baginsky, S., Fernie, A.R. (Eds.), Plant Systems Biology. Birkhäuser Verlag, Basel, 1123 
Switerland, pp. 245–275.. 1124 
Nishiumi, S., Shinohara, M., Ikeda, A., Yoshie, T., Hatan, N., Kakuyama, S., et al., 2010. 1125 
Serum metabolomics as a novel diagnostic approach for pancreatic cancer. 1126 
Metabolomics, 6(4), 518–528. 1127 
Normand, J., Li, R., Quillien, V., Nicolas, J.L., Boudry, P., Pernet, F., et al., 2014. Contrasted 1128 
survival under field or controlled conditions displays associations between mRNA levels 1129 
of candidate genes and response to OsHV-1 infection in the Pacific oyster Crassostrea 1130 
gigas. Mar. Genomics, 15, 95–102. 1131 
O’Neill, L.A., 2015. A broken krebs cycle in macrophages. Immunity, 42(3), 393–394. 1132 
O’Neill, L.A., Pearce, E.J., 2016. Immunometabolism governs dendritic cell and 1133 
macrophage function. J. Exp. Med., 213(1), 15–23. 1134 
O'Neill, L.A., Kishton, R.J., Rathmell, J., 2016. A guide to immunometabolism for 1135 
immunologists. Nat. Rev. Immunol., 16, 553–565. 1136 
Oden, E., Martenot, C., Berthaux, M., Travaillé, E., Malas, J.P., Houssin, M., 2011. 1137 
Quantification of ostreid herpesvirus 1 (OsHV-1) in Crassostrea gigas by real-time PCR: 1138 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
determination of a viral load threshold to prevent summer mortalities. Aquaculture, 1139 
317(1), 27–31. 1140 
OIE, 2016. Infection with ostreid herpesvirus 1 microvariants, In: Manual of Diagnostic Tests 1141 
for Aquatic Animals. World Organisation for Animal Health (OIE), Paris, France. 1142 
Owens, L., Malham, S., 2015. Review of the RNA interference pathway in molluscs 1143 
including some possibilities for use in bivalves in aquaculture. J. Mar. Sci. Eng., 3(1), 1144 
87–99. 1145 
Pallares-Méndez, R., Aguilar-Salinas, C.A., Cruz-Bautista, I., del Bosque-Plata, L., 2016. 1146 
Metabolomics in diabetes, a review. Ann. Med., 48(1–2), 89–102. 1147 
Palsson‐McDermott, E.M., O'neill, L.A., 2013. The Warburg effect then and now: From 1148 
cancer to inflammatory diseases. Bioessays, 35(11), 965–973. 1149 
Paul-Pont, I., Dhand, N.K., Whittington, R.J., 2013. Influence of husbandry practices on 1150 
OsHV-1 associated mortality of Pacific oysters Crassostrea gigas. Aquaculture, 412, 1151 
202–214. 1152 
Paul-Pont, I., Evans, O., Dhand, N.K., Whittington, R.J., 2015. Experimental infections of 1153 
Pacific oyster Crassostrea gigas using the Australian OsHV-1 µVar strain. Dis. Aquat. 1154 
Organ., 113(2), 137–147. 1155 
Pernet, F., Barret, J., Marty, C., Moal, J., Le Gall, P., Boudry, P., 2010. Environmental 1156 
anomalies, energetic reserves and fatty acid modifications in oysters coincide with an 1157 
exceptional mortality event. Mar. Ecol. Prog. Ser., 401,129–46. 1158 
Pernet, F., Lagarde, F., Jeannée, N., Daigle, G., Barret, J., Le Gall, P., et al., 2014. Spatial and 1159 
temporal dynamics of mass mortalities in oysters is influenced by energetic reserves and 1160 
food quality. PLOS ONE, 9, e88469. 1161 
Petton, B., Pernet, F., Robert, R., Boudry, P., 2013. Temperature influence on pathogen 1162 
transmission and subsequent mortalities in juvenile Pacific oysters Crassostrea gigas. 1163 
Aquacult. Env. Interac., 3, 257–273. 1164 
Phang, J.M., Donald, S.P., Pandhare, J., Liu, Y., 2008. The metabolism of proline, a stress 1165 
substrate, modulates carcinogenic pathways. Amino Acids, 35(4), 681–690. 1166 
Phang, J.M., Liu, W., Zabirnyk, O., 2010. Proline metabolism and microenvironmental stress. 1167 
Annu. Rev. Nutr., 30, 441–463. 1168 
Pisoschi, A.M., Pop, A., 2015. The role of antioxidants in the chemistry of oxidative stress: A 1169 
review. Eur. J. Med. Chem., 97, 55–74. 1170 
Preusse, M., Tantawy, M.A., Klawonn, F., Schughart, K., Pessler, F., 2013. Infection-and 1171 
procedure-dependent effects on pulmonary gene expression in the early phase of 1172 
influenza A virus infection in mice. BMC Microbiol., 13(1), 293, DOI: 10.1186/1471-1173 
2180-13-293 1174 
Purdy, J.G., Shenk, T., Rabinowitz, J.D., 2015. Fatty Acid elongase 7 catalyzes lipidome 1175 
remodeling essential for human cytomegalovirus replication. Cell Rep., 10(8), 1375–1176 
1385. 1177 
Ragg, N.L., King, N., Watts, E., Morrish, J., 2010. Optimising the delivery of the key dietary 1178 
diatom Chaetoceros calcitrans to intensively cultured Greenshell™ mussel larvae, Perna 1179 
canaliculus. Aquaculture, 306(1), 270–280. 1180 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
Ren, S., Shao, Y., Zhao, X., Hong, C.S., Wang, F., Lu, X., et al., 2016. Integration of 1181 
metabolomics and transcriptomics reveals major metabolic pathways and potential 1182 
biomarker involved in prostate cancer. Mol. Cell. Proteomics, 15(1), 154–163. 1183 
Ren, W., Chen, H., Renault, T., Cai, Y., Bai, C., Wang, C., et al., 2013. Complete genome 1184 
sequence of acute viral necrosis virus associated with massive mortality outbreaks in the 1185 
Chinese scallop, Chlamys farreri. Virol. J., 10(1), 110, DOI: 10.1186/1743-422X-10-110  1186 
Renault, T., Le Deuff, R.M., Cochennec, N., Chollet, B., Maffart, P., 1995. Herpes-like 1187 
viruses associated with high mortality levels in larvae and spat of Pacific oysters, 1188 
Crassostrea gigas: A comparative study, the thermal effects on virus detection in 1189 
hatchery-reared larvae, reproduction of the disease in axenic larvae. Vet. Res., 26(5–6), 1190 
539–43. 1191 
Renault, T., Arzul, I., 2001. Herpes-like virus infections in hatchery-reared bivalve larvae in 1192 
Europe: Specific viral DNA detection by PCR. J. Fish Dis., 24(3), 161–168. 1193 
Renault, T., Faury, N., Barbosa-Solomieu, V., Moreau, K., 2011. Suppression substractive 1194 
hybridisation (SSH) and real time PCR reveal differential gene expression in the Pacific 1195 
cupped oyster, Crassostrea gigas, challenged with Ostreid herpesvirus 1. Dev. Comp. 1196 
Immunol., 35(7), 725–735. 1197 
Renault, T., Moreau, P., Faury, N., Pepin, J.F., Segarra, A., Webb, S., 2012. Analysis of 1198 
clinical Ostreid herpesvirus 1 (Malacoherpesviridae) specimens by sequencing amplified 1199 
fragments from three virus genome areas. J. Virol., 86(10), 5942–5947. 1200 
Renault, T., Tchaleu, G., Faury, N., Moreau, P., Segarra, A., Barbosa-Solomieu, V., et al., 1201 
2014. Genotyping of a microsatellite locus to differentiate clinical Ostreid herpesvirus 1 1202 
specimens. Vet. Res., 45(1), 1–8. 1203 
Reuter, S., Gupta, S.C., Chaturvedi, M.M., Aggarwal, B.B., 2010. Oxidative stress, 1204 
inflammation, and cancer: How are they linked? Free Radic. Biol. Med., 49(11), 1603–1205 
1616. 1206 
Rosani, U., Varotto, L., Domeneghetti, S., Arcangeli, G., Pallavicini, A., Venier, P., 2015. 1207 
Dual analysis of host and pathogen transcriptomes in ostreid herpesvirus 1‐positive 1208 
Crassostrea gigas. Environ. Microbiol., 17(11), 4200–4212. 1209 
Rosenwasser, S., Ziv, C., van Creveld, S.G., Vardi, A., 2016. Virocell metabolism: Metabolic 1210 
innovations during host–virus interactions in the ocean. Trends Microbiol., 24(10), 821–1211 
832. 1212 
Rosi, A., Ricci‐Vitiani, L., Biffoni, M., Grande, S., Luciani, A.M., Palma, A., et al., 2015. 1H 1213 
NMR spectroscopy of glioblastoma stem‐like cells identifies alpha‐aminoadipate as a 1214 
marker of tumor aggressiveness. NMR Biomed., 28(3), 317–326. 1215 
Rubic, T., Lametschwandtner, G., Jost, S., Hinteregger, S., Kund, J., Carballido-Perrig, N., et 1216 
al., 2008. Triggering the succinate receptor GPR91 on dendritic cells enhances 1217 
immunity. Nat. Immunol., 9(11), 1261–1269. 1218 
Sanchez, E.L., Carroll, P.A., Thalhofer, A.B., Lagunoff, M., 2015. Latent KSHV infected 1219 
endothelial cells are glutamine addicted and require glutaminolysis for survival. PLOS 1220 
Pathog., 11(7), e1005052. 1221 
Sanchez, E.L., Lagunoff, M., 2015. Viral activation of cellular metabolism. Virology, 479, 1222 
609–618. 1223 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
Sanmartín, M.L., Power, D.M., de la Herrán, R., Navas, J.I., Batista, F.M., 2016. 1224 
Experimental infection of European flat oyster Ostrea edulis with ostreid herpesvirus 1 1225 
microvar (OsHV-1µvar): Mortality, viral load and detection of viral transcripts by in situ 1226 
hybridization. Virus Res., 217, 55–62. 1227 
Sauve, A.A., 2008. NAD+ and vitamin B3: From metabolism to therapies. J. Pharmacol. Exp. 1228 
Ther., 324(3), 883–893. 1229 
Schikorski, D., Faury, N., Pépin, J.F., Saulnier, D., Tourbiez, D., Renault, T., 2011a. 1230 
Experimental ostreid herpesvirus 1 infection of the Pacific oyster Crassostrea gigas: 1231 
Kinetics of virus DNA detection by q-PCR in seawater and in oyster samples. Virus 1232 
Res., 155, 28−34. 1233 
Schikorski, D., Renault, T., Saulnier, D., Faury, N., Moreau, P., Pépin, J.F., 2011b. 1234 
Experimental infection of Pacific oyster Crassostrea gigas spat by ostreid herpesvirus 1: 1235 
Demonstration of oyster spat susceptibility. Vet. Res., 42(1), 27, DOI: 10.1186/1297-1236 
9716-42-27 1237 
Schmitt, P., Santini, A., Vergnes, A., Degremont, L., de Lorgeril, J., 2013. Sequence 1238 
polymorphism and expression variability of Crassostrea gigas immune related genes 1239 
discriminate two oyster lines contrasted in term of resistance to summer mortalities. 1240 
PLOS ONE, 8(9), e75900. 1241 
Segarra, A., Pépin, J.F., Arzul, I., Morga, B., Faury, N., Renault, T., 2010. Detection and 1242 
description of a particular Ostreid herpesvirus 1 genotype associated with massive 1243 
mortality outbreaks of Pacific oysters, Crassostrea gigas, in France in 2008. Virus Res., 1244 
153(1), 92–99. 1245 
Segarra, A., Baillon, L., Tourbiez, D., Benabdelmouna, A., Faury, N., Bourgougnon, N., et 1246 
al., 2014a. Ostreid herpesvirus type 1 replication and host response in adult Pacific 1247 
oysters, Crassostrea gigas. Vet. Res., 45(1), 103, DOI: 10.1186/s13567-014-0103-x  1248 
Segarra, A., Mauduit, F., Faury, N., Trancart, S., Dégremont, L., Tourbiez, D., et al., 2014b. 1249 
Dual transcriptomics of virus-host interactions: Comparing two Pacific oyster families 1250 
presenting contrasted susceptibility to ostreid herpesvirus 1. BMC Genomics, 15(1), 580.  1251 
Segarra, A., Baillon, L., Faury, N., Tourbiez, D., Renault, T., 2016. Detection and 1252 
distribution of ostreid herpesvirus 1 in experimentally infected Pacific oyster spat. J. 1253 
Invertebr. Pathol., 133, 59–65. 1254 
Selak, M.A., Armour, S.M., MacKenzie, E.D., Boulahbel, H., Watson, D.G., Mansfield, 1255 
K.D., et al., 2005. Succinate links TCA cycle dysfunction to oncogenesis by inhibiting 1256 
HIF-α prolyl hydroxylase. Cancer Cell, 7(1), 77–85. 1257 
Sell, D.R., Strauch, C.M., Shen, W., Monnier, V.M., 2007. 2-Aminoadipic acid is a marker of 1258 
protein carbonyl oxidation in the aging human skin: Effects of diabetes, renal failure and 1259 
sepsis. Biochem J., 404(2), 269–277. 1260 
Semenza, G.L., 2010. HIF-1: Upstream and downstream of cancer metabolism. Curr. Opin. 1261 
Genet. Dev., 20(1), 51–56. 1262 
Senyilmaz, D., Teleman, A.A., 2015. Chicken or the egg: Warburg effect and mitochondrial 1263 
dysfunction. F1000Prime Rep., 7: 41, DOI: 10.12703/P7-41 1264 
Seo, J.Y., Cresswell, P., 2013. Viperin regulates cellular lipid metabolism during human 1265 
cytomegalovirus infection. PLOS Pathog., 9(8), e1003497. 1266 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
Sévin, D.C., Kuehne, A., Zamboni, N., Sauer, U., 2015. Biological insights through 1267 
nontargeted metabolomics. Curr. Opin. Biotechnol., 34, 1–8. 1268 
Shannon, P., Markiel, A., Ozier, O., Baliga, N.S., Wang, J.T., Ramage, D., et al., 2003. 1269 
Cytoscape: A software environment for integrated models of biomolecular interaction 1270 
networks. Genome Res., 13(11), 2498–504. 1271 
Shimahara, Y., Kurita, J., Kiryu, I., Nishioka, T., Yuasa, K., Kawana, M., et al., 2012. 1272 
Surveillance of type 1 ostreid herpesvirus (OsHV-1) variants in Japan. Fish Pathol., 1273 
47(4), 129–136. 1274 
Villas-Bôas, S.G., Smart, K.F., Sivakumaran, S., Lane, G.A., 2011. Alkylation or silylation 1275 
for analysis of amino and non-amino organic acids by GC-MS?. Metabolites, 1(1), 3–20. 1276 
Smuts, I., Van der Westhuizen, F.H., Louw, R., Mienie, L.J., Engelke, U.F., Wevers, R.A., et 1277 
al., 2013. Disclosure of a putative biosignature for respiratory chain disorders through a 1278 
metabolomics approach. Metabolomics, 9(2), 379–391. 1279 
Spencer, C.M., Schafer, X.L., Moorman, N.J., Munger, J., 2011. Human cytomegalovirus 1280 
induces the activity and expression of acetyl-coenzyme A carboxylase, a fatty acid 1281 
biosynthetic enzyme whose inhibition attenuates viral replication. J. Virol., 85(12), 1282 
5814–5824. 1283 
Spiegel, E., Howard, L., Spiegel, M., 1989. Extracellular matrix of sea urchin and other 1284 
marine invertebrate embryos. J. Morphol., 199(1), 71–92. 1285 
Stehbens, W.E., 2004. Oxidative stress in viral hepatitis and AIDS. Exp. Mol. Pathol., 77(2), 1286 
121–132. 1287 
Størseth, T.R., Hammer, K.M., 2014. Environmental metabolomics of aquatic organisms. 1288 
eMagRes, 2(4), DOI: 10.1002/9780470034590 1289 
Su, M.A., Huang, Y.T., Chen, I.T., Lee, D.Y., Hsieh, Y.C., Li, C.Y., et al., 2014. An 1290 
invertebrate Warburg effect: A shrimp virus achieves successful replication by altering 1291 
the host metabolome via the PI3K-Akt-mTOR pathway. PLOS Pathog., 10(6), e1004196. 1292 
Surazynski, A., Donald, S.P., Cooper, S.K., Whiteside, M.A., Salnikow, K., Liu, Y., et al., 1293 
2008. Extracellular matrix and HIF‐1 signaling: The role of prolidase. Int. J. Cancer, 1294 
122(6), 1435–1440. 1295 
Surjana, D., Halliday, G.M., Damian, D.L., 2010. Role of nicotinamide in DNA damage, 1296 
mutagenesis, and DNA repair. J. Nucleic Acids, Article ID 157591, DOI:  1297 
10.4061/2010/157591 1298 
Tallam, A., Perumal, T.M., Antony, P.M., Jäger, C., Fritz, J.V., Vallar, L., et al., 2016. Gene 1299 
Regulatory Network Inference of Immunoresponsive Gene 1 (IRG1) Identifies Interferon 1300 
Regulatory Factor 1 (IRF1) as Its Transcriptional Regulator in Mammalian 1301 
Macrophages. PLOS ONE, 11(2), e0149050. 1302 
Tamayo, D, Corporeau, C, Petton, B, Quéré, C, Pernet, F., 2014. Physiological changes in 1303 
Pacific oyster Crassostrea gigas exposed to the herpesvirus OsHV-1 µvar. Aquaculture, 1304 
432, 304–310. 1305 
Tannahill, G.M., Curtis, A.M., Adamik, J., Palsson-McDermott, E.M., McGettrick, A.F., 1306 
Goel, G., et al., 2013. Succinate is an inflammatory signal that induces IL-1 [bgr] 1307 
through HIF-1 [agr]. Nature, 496(7444), 238–242. 1308 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
Thai, M., Graham, N.A., Braas, D., Nehil, M., Komisopoulou, E., Kurdistani, S.K., et al., 1309 
2014. Adenovirus E4ORF1-induced MYC activation promotes host cell anabolic glucose 1310 
metabolism and virus replication. Cell Metab., 19(4), 694–701. 1311 
Thai, M., Thaker, S.K., Feng, J., Du, Y., Hu, H., Wu, T.T., et al., 2015. MYC-induced 1312 
reprogramming of glutamine catabolism supports optimal virus replication. Nat. 1313 
Commun., 6, Article number 8873, DOI: 10.1038/ncomms9873 1314 
Thompson, C.B., 2014. Wnt meets Warburg: Another piece in the puzzle? EMBO J., 33(13), 1315 
1420–1422. 1316 
Tilford, C.A., Siemers, N.O., 2009. Gene set enrichment analysis, in: Nikolsky Y., Bryant J. 1317 
(Eds.), Protein Networks and Pathway Analysis. Humana Press, Springer, New York, 1318 
USA, pp. 99–121. 1319 
Torres, M.A., Jones, J.D., Dangl, J.L., 2006. Reactive oxygen species signaling in response to 1320 
pathogens. Plant Physiol., 141(2), 373–378. 1321 
Touw, W.G., Bayjanov, J.R., Overmars, L., Backus, L., Boekhorst, J., Wels, M., et al., 2012. 1322 
Data mining in the life sciences with Random Forest: A walk in the park or lost in the 1323 
jungle? Brief. Bioinform., 14 (3),315-326. 1324 
Tretter, L., Patocs, A., Chinopoulos, C., 2016. Succinate, an intermediate in metabolism, 1325 
signal transduction, ROS, hypoxia, and tumorigenesis. BBA-Bioenergetics, 1857(8), 1326 
1086–1101. 1327 
Vander, Heiden, M.G., Cantley, L.C., Thompson, C.B., 2009. Understanding the Warburg 1328 
effect: The metabolic requirements of cell proliferation. Science, 324(5930), 1029–1033. 1329 
Vijayakumar, S.N., Sethuraman, S., Krishnan, U.M., 2015. Metabolic pathways in cancers: 1330 
Key targets and implications in cancer therapy. RSC Adv., 5(52), 41751–41762. 1331 
Vuoristo, K.S., Mars, A.E., van Loon, S., Orsi, E., Eggink, G., Sanders, J.P., et al., 2015. 1332 
Heterologous expression of Mus musculus immunoresponsive gene 1 (irg1) in 1333 
Escherichia coli results in itaconate production. Front. Microbiol., 6, 849, DOI: 1334 
10.3389/fmicb.2015.00849 1335 
Vyas, S., Chesarone-Cataldo, M., Todorova, T., Huang, Y.H., Chang, P., 2013. A systematic 1336 
analysis of the PARP protein family identifies new functions critical for cell physiology. 1337 
Nat. Commun., 4 Article number 2240, DOI: 10.1038/ncomms3240 1338 
Wang, T.J., Ngo, D., Psychogios, N., Dejam, A., Larson, M.G., Vasan, R.S., et al., 2013. 2-1339 
Aminoadipic acid is a biomarker for diabetes risk. J. Clin. Invest., 123(10), 4309–4317. 1340 
Weljie, A.M., Jirik, F.R., 2011. Hypoxia-induced metabolic shifts in cancer cells: Moving 1341 
beyond the Warburg effect. Int. J. Biochem. Cell Biol., 43(7), 981–989. 1342 
Whittington, R., Hick, P., Evans, O., Rubio, A., Dhand, N., Paul-Pont, I., 2016. Pacific oyster 1343 
mortality syndrome: A marine herpesvirus active in Australia. Microbiol. Aust., 37(3), 1344 
126–128. 1345 
Winter, G., Krömer, J.O., 2013. Fluxomics–connecting ‘omics analysis and phenotypes. 1346 
Environ. Microbiol., 15(7), 1901–1916. 1347 
Wishart, D.S., 2016. Emerging applications of metabolomics in drug discovery and precision 1348 
medicine. Nat. Rev. Drug Discov., 15, 473–484. 1349 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
Wu, H., Ji, C., Wei, L., Zhao, J., Lu, H., 2013. Proteomic and metabolomic responses in 1350 
hepatopancreas of Mytilus galloprovincialis challenged by Micrococcus luteus and 1351 
Vibrio anguillarum. J. Proteomics, 94, 54–67. 1352 
Xia, J., Wishart, D.S., 2010. MetPA: A web-based metabolomics tool for pathway analysis 1353 
and visualization. Bioinformatics, 26(18), 2342–2344. 1354 
Xia, J., Wishart, D.S., 2011. Web-based inference of biological patterns, functions and 1355 
pathways from metabolomic data using MetaboAnalyst. Nat. Protoc., 6, 743–760. 1356 
Xia, J., Bai, C., Wang, C., Song, X., Huang, J., 2015a. Complete genome sequence of Ostreid 1357 
herpesvirus-1 associated with mortalities of Scapharca broughtonii broodstocks. Virol. 1358 
J., 12(1), 110–119. 1359 
Xia, J., Sinelnikov, I.V., Han, B., Wishart, D.S., 2015b. MetaboAnalyst 3.0—making 1360 
metabolomics more meaningful. Nucleic Acid Res., 43(W1), W251–W257. 1361 
Xiong, X., Sheng, X., Liu, D., Zeng, T., Peng, Y., Wang, Y., 2015. A GC/MS-based 1362 
metabolomic approach for reliable diagnosis of phenylketonuria. Anal. Bioanal. Chem., 1363 
407(29), 8825–8833. 1364 
Yamamoto, K., Nagata, K., Ohara, H., Aso, Y., 2015. Challenges in the production of 1365 
itaconic acid by metabolically engineered Escherichia coli. Bioengineered, 6(5), 303–1366 
306. 1367 
Ye, Y., Xia, M., Mu, C., Li, R., Wang, C., 2016. Acute metabolic response of Portunus 1368 
trituberculatus to Vibrio alginolyticus infection. Aquaculture, 463, 201–208. 1369 
Yoshino, T.P., Bickham, U., Bayne, C.J., 2013. Molluscan cells in culture: Primary cell 1370 
cultures and cell lines 1. Can. J. Zool., 91(6), 391–404. 1371 
Young, T., Alfaro, A.C., Villas-Boas, S.G., 2015. Identification of candidate biomarkers for 1372 
quality assessment of hatchery-reared mussel larvae via GC/MS-based metabolomics. N. 1373 
Z. J. Mar. Freshwater Res., 49(1), 87–95. 1374 
Young, T., Alfaro, A.C., 2016. Metabolomic strategies for aquaculture research: A primer. 1375 
Rev. Aquacult., DOI: 10.1111/raq.12146 1376 
Young, T., Alfaro, A.C., Villas-Boas, S.G., 2016. Metabolic profiling of mussel larvae: 1377 
Effect of handling and culture conditions. Aquacult. Int., 24(3), pp. 843–856.  1378 
Yuan, W., Zhang, J., Li, S., Edwards, J.L., 2011. Amine metabolomics of hyperglycemic 1379 
endothelial cells using capillary LC–MS with isobaric tagging. J. Proteome Res., 10(11), 1380 
5242–5250. 1381 
Yuasa, H.J., Ball, H.J., 2015. Efficient tryptophan‐catabolizing activity is consistently 1382 
conserved through evolution of TDO enzymes, but not IDO enzymes. J. Exp. Zool. B 1383 
Mol. Dev. Evol., 324(2), 128–140. 1384 
Yuasa, H.J., Mizuno, K., Ball, H.J., 2015. Low efficiency IDO2 enzymes are conserved in 1385 
lower vertebrates, whereas higher efficiency IDO1 enzymes are dispensable. FEBS J., 1386 
282(14), 2735–2745. 1387 
Zaidi, N., Lupien, L., Kuemmerle, N.B., Kinlaw, W.B., Swinnen, J.V., Smans, K., 2013. 1388 
Lipogenesis and lipolysis: The pathways exploited by the cancer cells to acquire fatty 1389 
acids. Prog. Lipid Res., 52(4), 585–589. 1390 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
Zeitoun-Ghandour, S., Leszczyszyn, O.I., Blindauer, C.A., Geier, F.M., Bundy, J.G., 1391 
Stürzenbaum, S.R., 2011. C. elegans metallothioneins: Response to and defence against 1392 
ROS toxicity. Mol. Biosyst., 7(8), 2397–2406. 1393 
Zhang, J., Nuebel, E., Daley, G.Q., Koehler, C.M., Teitell, M.A., 2012. Metabolic regulation 1394 
in pluripotent stem cells during reprogramming and self-renewal. Cell Stem Cell, 11(5), 1395 
589–595. 1396 
Zhao, X.L., Han, Y., Ren, S.T., Ma, Y.M., Li, H., Peng, X.X., 2015. L-proline increases 1397 
survival of tilapias infected by Streptococcus agalactiae in higher water temperature. 1398 
Fish Shellfish Immunol., 44(1), 33–42. 1399 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
Figure 1. Metabolites detected as being significantly different (p < 0.05) between control and OsHV-
1 µVar-infected larvae. (A) Significant Analysis of Metabolites (SAM) plot. (B) Empirical Bayes 
Analysis of Metabolites (EBAM) plot. (C) Summary of statistically different metabolite levels between 
treatment groups with their respective Log2 fold change values (virus-infected [red circles] / control 
[green circles] larvae).  
 
Figure 2. Unsupervised multivariate cluster analyses of metabolite profiles from larvae infected with 
OsHV-1 µVar vs control larvae. (A) Hierarchical Cluster Analysis (Euclidian distance; Ward’s method). 
(B) Table of results from k-Means cluster analysis where k clusters = 2 (Cn = control sample n; Vn = 
virus-infected sample n). (C) Principal Component Analysis (PCA) score plot.  (D) PCA scree plot 
showing variation explained by n PC (blue line), and the cumulative variance explained in n PC’s 
(green line). 
 
Figure 3. Supervised multivariate classification analyses of metabolite profiles from larvae infected 
with OsHV-1 µVar vs control larvae. (A) Projection to Latent Structure Discriminant Analysis (PLS-DA) 
score plot with accuracy of 100%, multiple correlation coefficient (R
2
) of 96.9%, and cross-validated 
R
2
 (Q
2
) of 79.6%. (B) Variable Importance in Projection (VIP) scores for the PLS-DA model.   
 
Figure 4. Multivariate machine learning and predictive modelling of larval sample classes via Random 
Forest (RF) analysis with Monte-Carlo Cross Validation (MCCV). (A) Predictive accuracies of RF 
models with different n features. (B) Area Under Curve (AUC) generated from Receiver Operating 
Characteristic (ROC) curve analysis of RF models with 5, 10, 15, 25, 50 and 100 features. (C) AUC of 
the 5-feature RF model. (D) Predicted class probabilities (average of the MCCV) for each sample 
using the best classifiers (based on AUC) of the 5-feature RF model. (E) The average importance of 
metabolites in the 5-feature RF model based on ROC curve analysis, with the most discriminating 
feature in descending order of importance. (F) The selected frequencies of metabolites in the 5-
feature RF model based on ROC curve analysis.   
 
Figure 5. Secondary bioinformatics of annotated metabolites. (A) Topology-based pathway analysis 
showing metabolic networks in oyster larvae potentially affected by OsHV-1 µVar. The most 
impacted metabolic pathways are specified by the volume and the colour of the spheres (yellow = 
least relevant; red = most relevant) according to their statistical relevance and pathway impact (PI) 
values resulting from Quantitative Enrichment Analysis (QTA) and Network Topology Analysis (NTA), 
respectively. (B–E) Examples of four pathways containing relatively high metabolite coverages: (B) 
Tricarboxylic acid cycle (p < 0.001, FDR < 0.000, PI = 0.26); (C) Alanine, aspartate and glutamate 
metabolism (p < 0.001, FDR = 0.002, PI = 0.72); (D) Glutathione metabolism (p = 0.057, FDR = 0.107, 
PI = 0.48); (E) Cysteine and methionine metabolism (p = 0.033, FDR = 0.076, PI = 0.60). Boxes which 
vary from yellow to red represent metabolites (KEGG ID codes) that were detected and annotated 
with our methods. Their colour indicates the level of significance (light yellow: p > 0.05, light orange 
to red: p < 0.05) from unpaired t-tests (control vs treatment). Light blue boxes/compounds in the 
pathways were not detected, but were used as background information for QEA to calculate the 
proportion of identified compounds within each pathway, and in NTA to determine the position 
(relative-betweeness centrality) and importance of each metabolite.    
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Figure 6. Metabolite–metabolite Pearson correlation heatmaps of healthy control larvae (A) vs. 
unhealthy virus-exposed larvae (B). The order of metabolites are the same for each of the heatmaps 
so direct comparisons can be made for particular regions.   
 
Figure 7. Correlation Network Analysis of control (A) vs. virus exposed larvae (B). Metabolite–
metabolite Pearson correlations > 0.9 are represented by grey solid lines, whereas those that are < -
0.9 are represented by dashed grey lines. 
 
 
 
 
 
Supplementary Table 1. List of identified metabolites showing the effect of OsHV-1 infection on 
oyster larvae. Up and down arrows represent metabolite levels which were identified as being 
significantly higher or lower in the virus infected group compared to control animals (via t-test, SAM 
and/or EBAM), or with high (> 1.0) Variable of Importance (VIP) scores in the PLS-DA model. 
 
Supplementary Table 2. List of unannotated metabolites showing the effect of OsHV-1 infection on 
oyster larvae. Up and down arrows represent metabolite levels which were identified as being 
significantly higher or lower in the virus infected group compared to control animals (via t-test, SAM 
and/or EBAM), or with high (> 1.0) Variable of Importance (VIP) scores in the PLS-DA model.  
 
Supplementary Table 3. List of altered metabolic pathways in larval hosts during viral (OsHV-1 μVar) 
infection. 
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HIGHLIGHTS 
 
• Herpesvirus-induced metabolic responses were investigated in oyster larvae by GC-MS  
• Host metabolism changes are suggestive of Irg-1-like activation 
• Energy and lipid metabolism was substantially disturbed during infection  
• Activation of immunoresponsive gene 1 and the Warburg effect is hypothesised 
• Metabolomics is a powerful approach to study disease in early oyster life stage 
